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Zusammenfassung 
Fikoline gehören zur Gruppe der Triggerproteine, die den Lektinweg des 
Komplementensystems aktivieren und eine Klasse der Rezeptoren darstellen, die 
spezifisch an Zuckermoleküle der mikrobiellen Oberflächen binden und dadurch zur 
Aktivierung des Immunsystems führen.  
Das Ziel dieser Arbeit  ist das Bindungpotenzial der Mausfikoline A und B an 
unterschiedlichen Bakterien  in Screeningsassays zu erforschen.  Die 
Erkennungsmoleküle Ficolin-A und -B der Maus binden an Staphylokokken und 
Streptokokken mit unterschiedlicher Affinität. Sie erkennen dabei definierte 
Zuckerstrukturen auf bakteriellen Oberflächen sowohl bekapselter als auch unbekapselter 
Stämme.  Um den Einfluss der Bakterienkapsel auf die Fikolin-bakterielle Bindung zu 
zeigen, wurden Screeningsassays an den siebzehn verbreitetsten bekapselten Stämmen 
des Str. pneumonia, zwölf bekapselten Stämmen von S. aureus und an relevanten 
unbekapselten Stämmen von S. aureus (Wood) and Str. pneumonia (SCR2 and TIGR4) 
durchgeführt.  Es wurde festgestellt, dass unterschiedliche Bakterienstämme mit einer 
unterschiedlichen Affinität an die Mausfikoline binden. Fikolin-A bindet mit einer hohen 
Affinität an Str. pneumonia 7A und 32F, wogleich Fikolin-B mit den ähnlichen 
Ergebnissen an Str. pneumonia 6A and 11F bindet, wobei keins der Mausfikoline an 
Pneumokokkenstämme 19C, 9L und 9V eine Bindung gezeigt hat. 
Somit wurde in dieser Doktorarbeit nachgewiesen, dass die Fikoline an bekapselte 
Bakterienstämme als auch an unbekapselte binden können und komplexes 
Bindungsmuster erkennen können, dass sich auch von Humanfikolinen unterscheiden 
könnte. Beide Maus- und Humanfikoline können N-acetylierte Zuckerreste erkennen.  
Allerdings war es nicht möglich, bindungsessenzielle Kohlenhydrate zu bestimmen. Es 
scheint aber möglich zu sein, dass Mausfikoline ein komplexes Bindungmuster erkennen 
und viele Oligosaccharide mit unterschiedlichen Interaktionsseiten nachweisen können.  
Diese Arbeit untersuchte auch Fikolin-B und sein Bindungpotenzial in Anwesenheit der 
Calciumionen.  Die Bindung war nicht möglich, wenn Calzium der Lösung entzogen war. 
Um die Tatsache zu beweisen, dass Mausfikoline an unterschiedliche Liganden binden 
können, haben wir Kompetitivassays durchgeführt. Sie ergaben, dass Fikolin-A und -B 
unterschiedlich überlappende Bindungsstellen haben.  
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I. Introduction 
I.1 Innate immune system 
 
The immune system is divided into innate and adaptive. The innate immune response is 
also referred to as the first line of host defense, because it protects the host from the 
microorganisms, which could cause a disease (Janeway Jr. et al., 2005). Most of the 
pathogens are detected and destroyed within a short period of time by mechanisms of the 
innate immunity or kept under control until the adaptive immune response is ready to 
fight the infection. The mechanisms of the non-adaptive immunity act immediately and 
the early induced responses follow them; however, in contrast to the adaptive immune 
response, innate immunity does not contain any immunological memory. 
The body epithelia make up the first physical line of defense against infection. In case the 
microorganism manages to cross the epithelium, it is immediately recognized, ingested 
and destroyed by macrophages or neutrophils in most cases. Using their cell surface 
receptors, macrophages and neutrophils can discriminate between molecules present on 
pathogens from those on host cells. The macrophage mannose receptor binds to mannose 
and the scavenger receptor binds negatively charged ligands (for example, lipoteichoic 
acid or bacterial lipopolisaccharids). Macrophage mannose receptor is a cell-bound Ca
++
-
dependent lectin, while mannan-like binding lectin (MBL) binds the mannose or fucose 
residues of bacterial or viral surfaces. Ligation of many of the receptors on the surface of 
the pathogen leads to phagocytosis of the pathogen. Macrophages and neutrophils possess 
also lysosome vesicles, which contain enzymes and peptides, that can mediate the 
intracellular antimicrobial response. The phagosome fuses with one or more lysosomes to 
generate a phagolysosome in which the lysosomal contents are released to destroy the 
pathogen (Figure 1) (Janeway Jr. et al., 2005). 
In addition macrophages and neutrophils also produce nitric oxide (NO), the superoxide 
anion (O2-) and hydrogen peroxide (H2O2), the hydroxyl radical (OH
.
), the hypochlorite 
(OCl-) and the hypobromide (OBr-) ions which are directly toxic to bacteria. 
Neutrophils are short-lived compared to the macrophages which continue to produce new 
lysosomes and get activated by the pathogens to produce cytokines, chemokines, and 
other inflammatory mediators. Macrophages are able to set up an inflammation in the 
tissue and attract more neutrophils and plasma proteins to the site of infection. Figure 1 
displays the phagocytosis by macrophages. 
   Introduction 
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Figure 1. Phagocytes bear several different receptors that recognize microbial components and 
induce phagocytosis. The figure illustrates five such receptors on macrophages—CD14, CD11b/CD18 
(CR3), the macrophage mannose receptor, the scavenger receptor, and the glucan receptor, all of which 
bind bacterial carbohydrates. CD14 and CR3 are specific for bacterial lipopolysaccharide (LPS). (Janeway, 
Jr. et al., 2005). 
 
The complement system has an important role as part of the innate immunity. The 
antibacterial responses in the human body begin with complement activation, which 
promotes recruitment and activation of neutrophils and macrophages. The mechanism of 
complement activation is as follows: neutrophils stimulate Toll-like receptors (TLRs) on 
dendritic cells and macrophages. Their products are cytokines which stimulate the innate 
immune responses. The Figure 2 explains the connection between the innate immunity 
and complement system.  
   Introduction 
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Figure 2. Overview of bacterial immune responses (Rosenthal et al, 2007) 
 
The components of the complement system, distinct plasma proteases, induce the 
opsonization, phagocytosis and lysis of bacteria and pathogens in a series of 
inflammatory responses.  There are three pathways of complement activation: the 
classical pathway (CP), which is triggered by binding of the complement components 
C1q to antibody-complexed antigen by direct binding of C1q to the pathogen surface, or 
by binding of C1q to C reactive protein bound to the pathogen; the lectin pathway (LP), 
which is triggered by mannose-binding lectin and ficolins, normal serum constituents, 
that bind to the carbohydrate molecules on the bacterial surfaces; and the alternative 
pathway (AP), which is triggered directly on the pathogen surfaces (Janeway et al., 
2005). All of these pathways generate a crucial enzymatic activity that, in its turn, 
generates the effector molecules of the complement.   
The formation of C3-convertases it is a converging point of all three pathways of 
complement activation.  The C3-convertase of the alternative pathway is C3bBb and the 
C3-convertase of the classical pathway is C4b2a (Löffler, et  al., 2005). C3bBb and 
C4b2a bind to the surface of pathogen and cleave C3 into C3a and C3b. In the LP and AP 
multiple C3b-molecules bind to the complex of C4b2a (in the AP) or of C3bBb (in the 
LP). These molecules are then able to capture C5 through binding to an acceptor site on 
C3b. This binding makes C5 susceptible to cleavage by the serine protease activity of 
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C2a or Bb, generating the products C5a and C5b, and initiating the terminal pathway 
which leads to the formation of the membrane attack complex (MAC) (Janeway Jr. et al., 
2005). The next step in the generation of MAC is the consecutive binding of C6, C7, C8 
and C9. MAC integrated in the bacterial surface looks like a pore through which the 
water enters into the bacterial cell and makes it burst.  
 
I.2 Proteins of the lectin pathway of complement activation 
 
According to today’s knowledge there are two groups of trigger-proteins to activate the 
lectin pathway: mannose-binding lectin (MBL) and ficolins. 
MBL circulates in plasma as a free receptor. In humans, the MBL gene encodes for a 32 
kDa glycoprotein, showing the typical collectin structure consisting of an N-terminal 
cysteine-rich region, a collagen-like domain followed by a neck region and a C-terminal 
carbohydrate recognition domain (CRD) (Turner T. et al., 2000). MBL forms 
homotrimers composed of a collagenous triple helix subunit and several of these 
homotrimers assemble to form higher order oligomers. In this way, the lectin domains of 
the MBL (as in every collectin) undergo two grades of clustering during assembly. The 
effect of this clustering probably ensures that these molecules only bind with high affinity 
to dense sugar arrays, typically found on the surface of microbes. There is evidence that 
full biological function requires assembly to at least the tetrameric level (Yokota Y. et al., 
1995). 
The MBL recognizes certain bacterial surfaces that present an arrangement of mannose 
and fucose residues. MBL binds to monosaccharides such as N-acetyl-D-glucosamine, 
mannose, N-acetyl-D-mannosamine, L-fucose and glucose (Hansen M. et al., 2000) in a 
Ca
++
-dependent manner. But the only correct spacing of the mannose and fucose residues 
ensures the MBL-binding. Ligand binding to one single CRD, however, is very weak, 
and multiple contacts are necessary for activation. These repetitive carbohydrate 
structures are found on a wide range of microorganisms, including bacteria, viruses and 
fungi (Jack B. et al., 2001) (Townsend et al., 2001) (Jack B. et al., 2003), but not on 
mammalian cells, because of the prevalent termination of self-glycoproteins with sialic 
acid or galactose (Ezekowitz N. et al., 1998), (Wallis S. et al., 2002). Some bacteria 
protect themselves from MBL-mediated complement attack by sialylating their surface 
structures (Jack et al., 2001). 
   Introduction 
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The binding of MBL to bacterial surfaces induces phagocytosis and activates the lectin 
pathway of the complement system. To date three MBL associated serine proteases 
(MASP-1, MASP-2, MASP-3) have been identified in a complex with MBL. 
Ficolins were originally identified by scientists from Fukushima Medical University 
School of Medicine in 1991 as a transforming growth factor (TGF)-ß-binding protein 
(Ichijo et al., 1991). This is a group of proteins which possesses a collagen-like stem 
structure with a fibrinogen-like domain at the C-terminal end. 
Ficolins are built of structural subunits (34-40 kDa) of three identical polypeptide chains. 
Each subunit includes a short N-terminal region with a cysteine residue, a middle 
collagen-like domain, a short neck domain and as last follows a globular fibrinogen-like 
domain (Yokota et al., 1995). Although ficolins do not have a coiled-coil structure acting 
as the neck region like MBL (Holmskov et al., 2003), they form active oligomers where 
normally four subunits join together at the N-terminal regions (Holmskow et al., 2003). 
Ficolins do not contain a Carbohydrate Recognition Particle (CRP) as do other lectins. 
Figure 3 shows the best known collectins and ficolins in their trimeric subunits. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. The structures of collagenous lectins in animals. A) Trimeric subunit structures of human 
collectins and ficolins. The molecules are drawn approximately to scale. The number of amino acids spanning the 
collagen like domains, including interruptions, is indicated. Fibrinogen-like domains are represented as globular 
heads. Modified from (Holmskov et al., 2003). B) Multimeric structures of a) CL-L1 and CL-43 (trimeric native 
form), b) MBL, SP-A and FCN (“bundle of tulips” or sertiform oligomers of varying numbers of trimers), and c) SP-
D (cruciform oligomers comprised of four trimers). (Lillie et al., 2005). 
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Ficolins recognize a common carbohydrate N-Acetyl-D-Glucosamin (GlcNAc). The 
carbohydrate-binding activity of ficolins is executed by the fibrinogen-like domain which 
has a Ca
++
-dependent lectin activity. The fibrinogen-like domain shows similarity to the 
fibrinogen α and γ chains (Endo Y. et al., 2005).  
I.3 Pig, human and mouse ficolins in comparison to each other and 
their role in the bacterial recognition 
 
Pigs contain two closely related ficolin genes. Ficolin α is expressed in liver, bone 
marrow, spleen and lung (Ohashi H. et al., 1998), while Ficolin β is expressed in bone 
marrow and neutrophiles (Brooks S. et al, 2003). α- and β-Ficolins share about 82% 
identity at the amino acid level. 
Pig ficolin-α posseses N-glycosylated subunits of about 35 kDa (Ohashi and Erickson, 
1998) and its binding activity was shown in experiments with bacterial microorganisms. 
In a N-acetyl-D-glucosamine (GlcNAc) dependent manner ficolin-α can bind to 
Actinobacillus pleuropneumoniae serotype 5B (APP5) (Books S. et al., 2003), to LPS 
from Gram-negative bacteria of both the rough and the smooth types such as Escherichia 
coli, Salmonella typhimurium, S. enteriditis, S. abortus equi, Shigella flexeneri, 
Pseudomonas aeruginosa, Serratia marcescens (Nahid and Sungii, 2006). 
Ficolin β has a molecular weight of 39 kDa. It seems that ficolin β might have a local 
function as a secreted lectin at sites of inflammation where neutrophils are activated and 
are able to release ficolin β. That constitutes a bactericidal role in tissue. Both of pig 
ficolins also can activate the complement system. 
In the human body three types of ficolin can be described: L-ficolin, H-ficolin and M-
ficolin. L- and M-ficolins share 79% identity at the amino acid level, the H- and M-
ficolins are identical only to 45%. 
L-ficolin is a multimeric plasma protein with the molecular weight of 35 kDa. It is 
expressed in the liver. Matsushita and colleagues showed that the L-ficolin binds to the 
GlcNAc residue to galactose at the non-reducing end of the complex-type 
oligosaccharides and that does not bind to mannose. 
Many scientists showed in their experiments that L-ficolin can bind to bacterial surfaces. 
Matsushita and co-workers described the binding of L-ficolin to the bacterial strain of 
Salmonella typhimurium TV119 (this strain exposes GlcNAc). This Ca
++
-dependent 
binding increases the phagocytosis by neutrophils and monocytes. 
   Introduction 
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L-ficolin also binds to Escherichia coli and can be eluted with a mixture of 
monosaccharides (Lu and Le, 1998). 
L-ficolin and MASPs complexes from sera specifically bind to LTA from 
Staphyloccoccus aureus, pyogenes and agalastiae and initiate a C4 turnover (Lynch et 
al., 2004). 
Krarup and co-workers reported that L-ficolin binds to capsulated S. aureus and S. 
pneumoniae, but does not bind to the non-capsulated strains. This is different from H-
ficolin and MBL binding properties. The results indicated that the binding of each lectin 
are directed toward different PAMPs and are specific. 
L-ficolin binds to Streptococcus pneumoniae 11F and this interaction can be inhibited by 
N-acetylated compounds, either sugars (GlcNAc, ManNAc, GalNAc) or other molecules 
like CysNAc, GlyNAc, and acetylcholine (Krarup et al., 2004). This finding shed some 
doubt on the lectin feature of L-ficolin and suggests that it might be considered as an 
acetyl-binding protein instead. 
H-ficolin was initially identified as a serum-antigen detected by auto-antibodies found in 
some patients with systemic lupus erythematosus (Inaba et al., 1990). The gene encoding 
H-ficolin (FCN3) is located on chromosome 1 and the open reading frame encodes for 
299 amino acids that reveal a domain organization similar to L-ficolin (Sugimoto et al., 
1998). 
H-ficolin is expressed by hepatocytes, bile duct epithelial cells, and in the lung by ciliated 
bronchial and type II alveolar epithelial cells (Akaiwa et al., 1999). 
H-ficolin is found in circulation at a median concentration of 18.4 µg/ml (Krarup et al., 
2005) as higher order oligomers whose 35 kDa subunits are linked by disulfide bonding 
(Yae et al., 1991). Hexamers of trimeric subunits were visualized by electron microscopy 
(Sugimoto et al., 1998) and it was also reported that H-ficolin shows a Ca
++
-independent 
lectin activity which can be inhibited by GlcNAc and GalNAc. 
The biological significance of H-ficolin as a lectin has been investigated by studying its 
binding potential to different strains and serotype forms of bacteria including S. 
pneumoniae, E.coli, S.aureus and Aerococcus viridans. Only A. viridans was found to be 
recognized and the binding specificity was assigned to a particular polysaccharide, 
namely PSA, present on this microorganism (Matsushita et al., 2002). 
H-ficolin isolated from serum is associated with MASP-1, MASP-2, MASP-3, and 
MAp19, and the H-ficolin/MASP complex is able to activate complement by cleavage of 
C4 upon binding to the PSA ligand (Matsushita et al., 2002). 
   Introduction 
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M-ficolin is expressed in peripheral blood leukocytes and the gene (FCN1) has been 
mapped to chromosome 9 in proximity to the gene encoding L-ficolin (FCN2) 
(Matsushita et al., 1996; Lu et al., 1996). M-ficolin contains a 27 amino acid potential 
leader peptide, as well as the short N-terminal sequence followed by the collagen-like and 
the fibrinogen-like domains (Lu et al., 1996). By screening a number of leukocyte cell 
lines it was shown that M-ficolin mRNA is synthesized in peripheral blood monocytes 
(PBM) as well as by cells of the monocyte-like cell line U937, and is downregulated 
when the cells differentiate into macrophages (Lu et al., 1996). M-ficolin was found on 
the surface of PBMs (Teh et al., 2000). In the same report M-ficolin showed GlcNAc 
affinity. Furthermore, it was shown that phagocytosis of Escherichia coli K12 by U937 
cells could be inhibited by anti-M-ficolin-fibrinogen antibodies (Teh et al., 2000). Due to 
these findings, Teh and co-workers suggested a putative role for M-ficolin in innate 
immunity by acting as a phagocytic receptor for pathogens (Teh et al., 2000). In contrast, 
M-ficolin protein was recently localized in secretory granules in the cytoplasm of 
neutrophils, monocytes, and type II alveolar epithelial cells in lung (Liu et al., 2005b). 
However, M-ficolin could not be detected in normal serum and has recently been secreted 
from monocytes and macrophages and also from granules of neutrohiles (Liu et al., 2005; 
Honore et al., 2008). These facts led to the hypothesis that M-ficolin might act as an 
acute phase protein that is temporarily stored in the secretory granules of the leukocytes 
to be secreted into local areas where it could execute its functions in host defense upon 
the right stimuli, similar to ficolin-β in pigs. 
In addition, M-ficolin coprecipitated with MASP-1 and -2, and the complexes were able 
to cleave C4 on GlcNAc-coated microplates. Regarding its binding specificities, Liu and 
co-workers found positive binding of M-ficolin to several neoglycoproteins bearing 
GlcNAc, GalNAc and syalil-LacNAc (Liu et al., 2005b). Interestingly, M-ficolin was 
found to interact with a rough-type of Staphylococcus aureus (LT2) but not with the 
smooth-type strain TV119, whereas just the opposite is true for L-ficolin (Matsushita et 
al., 1996), indicating that the spectrum of bacterial recognition might be different among 
ficolins. 
Mice, as well as rats, have two ficolin forms, termed ficolin-A and –B. The ficolin-A 
gene was first isolated by Fujimori and co-workers in 1998 from a mouse liver library 
(Fujimori et al., 1998). Ficolin-A is a plasma protein with a molecular weight of 37 kDa, 
highly expressed in liver and spleen with binding affinity for elastin and GlcNAc 
(Fujimori et al., 1998). Under the electron microscope, ficolin-A displayed the typical 
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parachute-like structure composed of four trimers of fibrinogen domains (12-mers) 
(Ohashi and Erickson, 1998). 
Liu and co-workers showed that ficolin-A mRNA is expressed as early as on embryonic 
day (E) 12.5, displaying an increase during development, peaking around birth, and 
slightly declining in the adult stages (Liu et al., 2005a). In addition, in situ hybridisation 
studies indicated that ficolin-A mRNA was mainly localized in the liver between two 
hepatic cords and in the red pulp of the spleen. These observations, together with further 
immunohistochemical analysis revealing a distribution pattern of ficolin-A comparable to 
the Kupffer cells in liver, suggest that ficolin-A mRNA is expressed by macrophages (Liu 
et al., 2005a). 
Ficolin-B was first characterized by Ohashi and Erickson in 1998 as a mouse ficolin 
different from the plasma ficolin (ficolin-A), with a strong mRNA expression in bone 
marrow and a weak expression in spleen (Ohashi and Erickson, 1998). Ficolin-B mRNA 
was detected in the spleen at all time points examined after birth, indicating a 
complementary expression of ficolin-A and –B in spleen (Liu et al., 2005a). Regarding 
the specific cell types expressing ficolin-B, distinct cell lineages of sorted bone marrow-
derived cells showed different expression patterns with high levels in myeloid cells (Gr-
1
+
 and Mac-1
+
) and no expression in  the Ter119
+
 erythroid, the T-cell (CD3e
+
), or the B-
cell (B220
+
) lineages (Liu et al., 2005a).  
I.4 General characteristics of bacteria and their interaction with the 
immune system of mammalians  
 
Bacteria are unicellular microorganisms and they can have a wide range of shapes such as 
spheres, rods and spirals. The majority of the bacteria are rendered harmless or beneficial 
by the protective effects of the immune system. A few pathogenic bacteria can also cause 
infectious diseases and shut down the immune system which tries to defeat them.  
Bacteria are prokaryotes, which do not contain a nucleus. Bacterial cells are about 10 
times smaller than eukaryotic cells, are typically 0,5 – 5 µm in length and surrounded by 
a lipid membrane which encompasses the contents of the cell and acts as a barrier to hold 
nutrition, proteins and other essential components of the cytoplasm within the cells. 
Many important biochemical reactions occur due to concentration gradients across 
membranes. 
 
   Introduction 
21 
 
I.5 Bacterial surface layers and their roles in the immunological 
evasion of bacteria 
 
I.5.1 Cell wall and peptidoglycan 
 
Around the outside of the membrane is the bacterial cell wall, its primary function is to 
protect a bacterial cell from internal turgor pressure caused by the much higher 
concentrations of proteins and other molecules inside of the cell compared to its external 
environment. Bacterial cell wall contains peptidoglycan (poly-N-acetylglucosamine and 
N-acetylmuramic acid), called murein, which is made of polysaccharide chains 
crosslinked by unusual peptides of D-amino-acids (von Heijenoort et al., 2001). 
Peptidoglycan is responsible for the rigidity of the bacterial call wall and for the 
determination of the cell shape.  
The primary chemical structures of peptidoglycans of both Gram-positive and Gram-
negative bacteria have been established; they consist of a glycan backbone of repeating 
groups of β1, 4-linked disaccharides of β1,4-N-acetylmuramyl-N-acetylglucosamine. 
Tetrapeptides of L-alanine-D-isoglutamic acid-L-lysine (or diaminopimelic acid)-n-
alanine are linked through the carboxyl group by amide linkage of muramic acid residues 
of the glycan chains; the D-alanine residues are directly cross-linked to the ε-amino group 
of lysine or diaminopimelic acid on a neighboring tetrapeptide, or they are linked by a 
peptide bridge (Baron S. et al., 2004). In S. aureus peptidoglycan, a glycine pentapeptide 
bridge links the two adjacent peptide structures. The extent of direct or peptide-bridge 
cross-linking varies from one peptidoglycan to another. The staphylococcal 
peptidoglycan is highly cross-linked, whereas that of E coli is much less so, and has a 
more open peptidoglycan mesh (Baron S. et al., 2004). The diamino acid providing the ε-
amino group for cross-linking is lysine or diaminopimelic acid, the latter being uniformly 
present in Gram-negative peptidoglycans.  
The ß-1,4 glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine is 
specifically cleaved by the bacteriolytic enzyme lysozyme. Widely distributed in nature, 
this enzyme is present in human tissues and secretions and can cause complete digestion 
of the peptidoglycan walls of sensitive organisms. When lysozyme is allowed to digest 
the cell wall of Gram-positive bacteria suspended in an osmotic stabilizer (such as 
sucrose), protoplasts are formed. These protoplasts are able to survive and continue to 
grow on suitable media in the wall-less state. Gram-negative bacteria treated similarly 
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produce spheroplasts, which retain much of the outer membrane structure. The 
dependence of bacterial shape on the peptidoglycan is shown by the transformation of 
rod-shaped bacteria to spherical protoplasts (spheroplasts) after enzymatic breakdown of 
the peptidoglycan. The mechanical protection afforded by the wall peptidoglycan layer is 
evident in the osmotic fragility of both protoplasts and spheroplasts. 
 
I.5.2 Gram-positive and Gram-negative bacteria 
 
According to the comparison of their cell wall, bacteria can be classified as Gram-
positive and Gram-negative. Gram-positive bacteria possess a thick cell wall containing 
many layers of peptidoglycan and teichoic acids, which are polyalcohols imbedded in the 
cell wall. The teichoic acids charge negatively the Gram-positive cell wall by the 
presence of phosphodiester bonds.  
In contrast, gram-negative bacteria have a relatively thin cell wall consisting of a few 
layers of peptidoglycan surrounded by a second lipid membrane containing 
lipopolysaccharides (LPS) and lipoproteins, which face the external environment and are 
responsible for many antigenic properties (Hugenholz P. et al., 2002). Table 1 shows the 
structure of a typical LPS molecule.  
 
Table 1. The three major, covalently linked regions that form the typical LPS (Baron S., et al., 2004). 
 
The highly charged nature of the lipopolysaccharides confers an overall negative charge 
to the Gram-negative cell wall. As a phospholipid bilayer, the lipid portion of the outer 
membrane is largely impermeable to all charged molecules.  
The LPS of all Gram-negative species are also called endotoxins, thereby distinguishing 
these cell-bound, heat-stable toxins from heat-labile, protein exotoxins secreted into 
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culture media. Endotoxins possess an array of powerful biologic activities and play an 
important role in the pathogenesis of many Gram-negative bacterial infections. In 
addition to causing endotoxic shock, LPS is pyrogenic, can activate macrophages and 
complement, is mitogenic for B lymphocytes, induces interferon production, causes 
tissue necrosis and tumor regression, and has adjuvant properties (Baron S., et al., 2004). 
The endotoxic properties of LPS reside largely in the lipid A components. Usually LPS 
molecules have three regions: the lipid A structure required for insertion in the outer 
leaflet of the outer membrane bilayer; a covalently attached core composed of 2-keto-
3deoxyoctonic acid (KDO), heptose, ethanolamine, N-acetylglucosamine, glucose, and 
galactose; and polysaccharide chains linked to the core. Fig 1.4 shows the structure of 
bacterial surfaces. The polysaccharide chains constitute the O-antigens of Gram-negative 
bacteria, and the individual monosaccharide constituents confer serologic specificity on 
these components. Figure 4 shows the main differences between gram-positive and gram 
negative bacteria. 
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Figure 4. Comparison of the thick cell wall of Gram-positive bacteria with the comparatively thin cell 
wall of Gram-negative bacteria. Note the complexity of the Gram-negative cell envelope (outer membrane, 
its hydrophobic lipoprotein anchor; periplasmic space) (Baron S., et al., 2004). 
 
I.5.3 Capsule and slime layer 
 
Capsules or slime layers are produced by many bacteria to surround their cells with 
relatively thick layer of the viscous gel, and vary in structural complexity: ranging from a 
disorganised slime layer of extra-cellular polymer, to a highly structured capsule or 
glycocalyx. Capsules may be up to 10 µm thick and can protect cells from engulfment by 
eukaryotic cells, such as macrophages (Stokes R., et al, 2004). They can also act as 
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antigens and be involved in cell recognition, as well as aiding attachment to surfaces and 
the formation of biofilms (Daffe M., et al., 1999). Not all bacterial species produce 
capsules; however, the capsules of encapsulated pathogens are often important 
determinants of virulence. Encapsulated species are found among both Gram-positive and 
Gram-negative bacteria. In both groups, most capsules are composed of high molecular-
weight viscous polysaccharides that are retained as a thick gel outside the cell wall or 
envelope. Cell viability is not affected when capsular polysaccharides are removed 
enzymatically from the cell surface. However capsules confer resistance to phagocytosis 
and hence provide the bacterial cell with protection against host defenses to invasion. 
(Baron S., et al., 2004). 
I.5.4 Surface-layer and endospores 
 
A surface-layer (S-layer) is a part of the cell envelope in the bacteria and it consists of a 
monomolecular layer composed of identical proteins or glycoprotein and enclosing the 
whole cell surface. S-layer proteins are poorly or not at all conserved and can differ even 
between related species. Depending on species S-layers have a thickness between 5-25 
nm in diameter (Sleytr U., et al., 2007). 
Depending on the type of the cell wall the S-layers are fixed differently. In Gram-
negative bacteria S-layers are associated to the LPS via ionic, carbohydrate-carbohydrate, 
protein-carbohydrate interactions or/and protein-protein interactions. In the Gram-
positive bacteria whose S-layers contain a surface layer homology domain the binding 
occurs to the peptidoglycan and to a secondary cell wall polymer. 
The biological functions of the S-layer are protection against bacteriophages and 
phagocytosis, resistance against low pH, barrier against lytic enzymes, adhesion, 
stabilization of the membrane. 
Some bacteria are able to adapt to stress and form endospores. The endospores are the 
bacterial survival structures which are resistant to many types of different chemical and 
environmental stresses   
The assembly of these extracellular structures is dependent on bacterial secretion 
systems. These transfer proteins from the cytoplasm into the periplasm or into the 
environment around the cell. Many types of secretion systems are known and these 
structures are often essential for the virulence of pathogens, and, therefore, intensively 
studied. 
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Table 2 displays the structures of the bacterial cell envelope, it’s functions and chemical 
constituents.  
 
Structure Primary functions Chemical Constituents 
Cytoplasmic 
membrane 
Energy production, metabolite 
transport, synthesis of cell wall 
and capsule, support 
Phospholipid bilayer, transport 
proteins, enzymes  
Gram-positive  
cell wall 
  
Peptidoglycan 
Osmotic stability, structural 
integrity, cell shape,  
permeable to antibiotics 
Thick meshwork of peptide  
crosslinked polysaccharide  
chains 
Teichoic and 
lipoteichoic acids    
Adhesion to the host cells, weak 
endotoxin activity, antigenic 
Polymers of substituted  ribitol 
 or glycerol phosphate 
Proteins  
Adhesion to the host cells, 
antyphagocytic, antygenic 
 
Gram-cell negative 
cell wall 
  
Peptidoglycan as in Gram-positive cell wall 
Thinner version of that found in 
Gram-positive bacteria; linked  
to lipoproteins, that are anchored 
in outer membrane 
Periplasmic space   
Transport of nutrients,  
degradation of the 
macromolecules 
Between cytoplasmic outer 
membranes; carrier proteins and 
hydrolytic enzymes 
Outer membrane  
Structural support, uptake of 
metabolites, permeability  
barrier, protection, antigenic 
Phospholipid bilayer, porins, 
transport and other proteins, 
lipopolysaccharide 
Lipopolisaccharide 
Endotoxin activity, 
anticomplement activity 
 lipid A, core polysaccharide, O 
antigen 
Porin channel 
Allow small and hydrophilic 
molecules to pass outer  
membrane 
Porin proteins 
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Capsule Antiphagocytic 
Layers of polysaccharides and 
polypeptides 
Table 2. Bacterial envelope and associated structures. The bold marked structures lay on outer surface 
layer and have a direct contact with ficolins. 
  
I.6 Some microbial organisms and their biology 
I.6.1 Staphylococcus aureus 
 
S. aureus belongs to the Gram-positive cocci and grows in grape-like clusters. The 
bacteria are between 0,8 – 1,2 μm in diameter. Major contributors to the virulence of S. 
aureus are the capsule, protein A, lipoteichoic and teichoic acids on the bacterial surface. 
Encapsulated bacteria are better protected from phagocytosis. Protein A inhibits 
complement fixation and opsonization and is also a part of antibody dependent cellular 
cytotoxity by binding to antibodies. Lipoteichoic and teichoic acids promote adherence to 
mucosal surfaces and persistence in tissues by binding to fibronectin. 
The members of the genus Staphylococcus are Gram-positive cocci (0.5-1.5 μm) and 
contain unsaturated polyisoprenoid side chains. 
S. aureus is catalase-positive and is able to convert H202 to water and oxygen that reduces 
phagocytic killing. Coagulase helps localize infection by forming fibrin layer around 
abscesses.  
S. aureus produces different toxins as leukocidins, enterotoxins A, B, C, D and E, 
exfoliative toxins A and B and toxic shock syndrome toxin 1.  Toxic shock syndrome 
toxin 1 acts as super-antigen and can cause toxic shock syndrome and death. S. aureus is 
commonly present on skin, which can cause nosocomial wound infections. Among the 13 
known serotypes, T-5 and T-8 account for approximately 75% of S. aureus infections 
(Kraup A. et al, 2005).  
S. aureus usually causes a variety of diseases either by toxin production or invasion, such 
as erythema, food poisoning and abscess. 
 
I.6.2 Streptococcus pneumonia 
 
Str. pneumoniae, or pneumococcus, is the most common streptococcal pathogen in 
mammalians. Str. pneumoniae is Gram-positive, alpha-hemolytic diplococcus. These 
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bacteria grow in pairs or chains. The serotypes of Str. pneumoniae are divided in groups 
based on the serologic identification of group-specific C-carbohydrates on the cell-wall. 
Str. pneumoniae is catalase negative and can be encapsulated. 
Its virulence is based on the polysaccharide capsule, pneumolysins, pneumococcal IgA 
protease and neuraminidase. The polysaccharide capsule prevents phagocytosis by host 
immune cells by inhibiting C3b opsonization of the pneumococcal cells. Pneumolysins 
lyse blood cells and platelets and stimulate release of lysosomal enzymes. Pneumococcal 
IgA protease cleaves secretory IgA and increases adherence to mucosal surfaces, while 
neuraminidase promotes bacterial spread into tissue. 
Those bacteria usually cause the variety of diseases of the respiratory system, 
inflammations of the upper skin layers and mucous membranes. 
 
I.6.3 Escherichia coli 
 
E. coli is facultative anaerobe, Gram-negative strain, permitting survival in the 
gastrointestinal tract of mammalians. All strains produce endotoxin that is responsible for 
many of the systemic manifestations of infection such as high fever, hypotension, shock 
or disseminated intracellular coagulation or urinary tract infections. 
 
I.6.4 Candida albicans 
 
Candida albicans is part of the normal flora in mucous membranes. C. albicans 
represents a diploid dimorphic filamentous fungus, that is composed of a mass of 
branching threadlike tubular filaments (hyphae), that elongate at their tips. 
Fungi are eukaryotic organisms whose cells possess a membrane-enclosed nucleus and 
various organelles. Fungal membranes contain ergosterol rather than cholesterol found in 
other eukaryotic membranes. The cell wall surrounding fungal cells, which differs in 
composition from bacterial cell walls, contains chitin, glucans, and protein. 
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II. Materials and Methods 
II.1 Materials 
II.1.1 Chemicals, solutions and media 
 
Ampicillin, >98% 
 
Sigma-Aldrich  
all other chemicals and solutions of analytical grade Sigma-Aldrich or Merck 
Chelating Sepharose Fast Flow  GE Healthcare 
Coomassie Brilliant Blue R250 Fluka 
H2O (deionized) Milli Q UF Plus system 
Heparin Sigma-Aldrich 
Hygromycin-B Invitrogen 
Insekt Express Medium Cambrex 
Kanamycin Invitrogen 
Methanol, technical grade Merck 
Nowa Solution A+B (ECL) MoBiTec 
SDS-PAGE Molecular weight standard, broad range  Biorad 
TEMED, Tetramethylethylendiamin  Biorad 
Triton X-100 GE Healthcare 
Tween 20 Fluka 
Table 3. Chemicals, solutions and media 
 
II.1.2 Kits 
 
BCA™ Protein Assay Kit Pierce 
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II.1.3 Bacterial strains 
 
Short name of a bacterial strain 
 
Whole name of the bacterial strain 
Sa1 Staphylococcus aureus T-1 
Sa2 Staphylococcus aureus T-2 
Sa3 Staphylococcus aureus T-3 
Sa4 Staphylococcus aureus T-4 
Sa5 Staphylococcus aureus T-5 
Sa6 Staphylococcus aureus T-6 
Sa7 Staphylococcus aureus T-7 
Sa8 Staphylococcus aureus T-8 
Sa9 Staphylococcus aureus T-9 
Sa10 Staphylococcus aureus T-10 
Sa11 Staphylococcus aureus T-11 
Sa12 Staphylococcus aureus T-12 
Sa Wood Staphylococcus aureus Wood 
Sp1 Streptococcus pneumonia 14 
Sp2 Streptococcus pneumonia SCR 
Sp3 Streptococcus pneumonia 7A 
Sp4 Streptococcus pneumonia 27 
Sp5 Streptococcus pneumonia 6A 
Sp6 Streptococcus pneumonia TIGR4 
Sp7 Streptococcus pneumonia 9L 
Sp8 Streptococcus pneumonia 6B 
Sp9 Streptococcus pneumonia 19C 
Sp10 Streptococcus pneumonia 19F 
Sp11 Streptococcus pneumonia 32F 
Sp12 Streptococcus pneumonia 23F 
Sp13 Streptococcus pneumonia 7F 
Sp15 Streptococcus pneumonia 11F 
Sp16 Streptococcus pneumonia 1 
Sp18 Streptococcus pneumonia 9V 
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Sp22 Streptococcus pneumonia 11D 
E. coli Escherichia coli  
Ca Candida albicans 
Table 4. Bacterial strains 
 
II.1.4 Proteins 
 
To study the binding affinities of murine ficolins to microorganisms, mouse recombinant 
ficolin A and B were expressed in Drosophila Schneider 2 cell line, purified by ion metal 
affinity chtomatography and stored frozen in a concentration of 1 – 1,6 mg/ml.   
 
II.1.5 Eukaryotic cell lines 
 
Drosophila Schneider 2 (S2) cell line: (Invitrogen) derived from a primary culture of late 
stage (20-24 hours old) Drosophila melanogaster embryos (Schneider, 1972). The S2 cell 
line and the DES
®
 system are used specially for the high yield expression of heterologous 
proteins which are secreted into the culture medium, thus avoiding cell lysis steps and 
facilitating the purification of the recombinant protein from the cell supernatant. S2 cells 
were grown as semi-adherent monolayers at 28°C without CO2 supply in insect media 
(Insect X-press, Cambrex) containing 100 mg/l kanamycin, and were regularly split at a 
1:2 to 1:5 ratio when they were 90-100% confluent. 
 
II.1.6 Buffers and mediums 
 
TBS/Tween/Ca
2+
-buffer: 
1L of buffer contains 25 mM of Tris Base, 140 mM of NaCl and 2 mM KCl and 0.05% 
of Tween 20 and 5 mM CaCl, pH was adjusted to 7,4. The buffer was stored at the 4˚C. 
TBS/Tween/EDTA-buffer: 
1L of buffer contains 10mM EDTA, 25mM Tris Base and 0,005% of Tween20. pH was 
adjusted to 7,4. The buffer was stored at the 4˚C. 
TBS/Tween/NaCl-buffer: 
1L of buffer contains 2M NaCl, 25mM Tris Base and 0,005% of Tween20. pH was 
adjusted to 7,4. The buffer was stored at the 4˚C. 
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PBS: 
1L of buffer contains 137 mM NaCl, 2.7 mM KCl, 2 mM K2HPO4 and 10 mM Na2HPO4. 
pH was adjusted to 7.4. The buffer was stored at room temperature. 
4 x Laemli buffer: 
1L of buffer contains 120 mM Tris Base, 0.95 M glycine and 0.5% SDS. 
Basic Medium: 
1 L of basic medium contains 10 g of casein hydrolysate (Peptone), 5 g of yeast extract, 5 
g of NaCl, 1 g of Glucose, 1g of K2HPO4 ∙3H2O. pH was adjusted to 7,2. 
 
II.1.7 Software and databases 
 
Peptidoglycan structures of bacteria (at molecular level) were obtained from PubMed 
publications and databases. Screening analysis of bacterial and ficolin binding was 
performed using the BD FACSDiva™ software (2006, flow cytometry acquisition and 
analysis software) and WinMDI Software (Version 2.9). The curves for competitive 
assays were plotted with Microsoft Excel 2002 for Windows XP. 
 
 
II.2 Methods  
 
II.2.1 Cell culture techniques 
 
II.2.1.1 Culture of Drosophila Schneider-2 (S2) cells in the mini PERM Bioreactor  
(Greiner bio-one) 
 
Ficolin-A/-B-transfected DS-2 cells (Runza, V., “Cloning and Characterization of Mouse 
Ficolins-A and -B”, doctoral thesis, 2006) were used to produce recombinant ficolin A 
and B. Cells were grown in suspension in a mini bioreactor containing with with 10 
μg/ml of heparin in the production module to avoid cell adherence or clumping. 
3 x 10
6
 cells/ml in 40 ml total volume (20ml fresh medium + 20ml conditioned medium) 
were inoculated into the production module. The nutrition module was filled with 400 ml 
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complete medium. Cells were cultivated at room temperature at a turning speed of 5 rpm. 
The growing medium was changed once a week. 
 
II.2.1.2 Induction of protein expression 
 
Cells were harvested every seventh day after inoculation, by removing 2 x 10 ml cell 
suspension from the production module. Each 10 ml were poured into a 50 ml tube and 
topped up with fresh medium. To induce ficolin expression the cell suspension was 
supplemented with CuSO4 (at a final concentration of 500 μM). The cells were incubated 
under rotation for 3 days. Afterwards, cells were spun by 3000 g for 10 min and the 
supernatant collected and purified by ion-metal affinity chromatography (see sec. 
II.II.2.2.1).  
To check for a positive protein expression, supernatant aliquots were taken 2-3 days after 
induction and analysed by Western Blot. 
 
II.2.2 Protein-biochemical techniques 
 
II.2.2.1 Purification of recombinant ficolins by ion-metal affinity chromatography 
 
Due to the features of the pMT/BiP/V5-His A expression vector in which the ficolin 
genes were cloned (Runza, V., 2005: Cloning and Charakterization of Mouse Ficolins A 
and B, doctoral Thesis), the recombinant ficolins (rfcn) were fused to a C-terminal V5- 
and His- tags, and secreted into the culture medium, enabling the (i) purification of the 
protein from the insect medium by His-tag specific ion-metal affinity chromatography 
(IMAC) and (ii) the detection by immunoblotting with an anti-V5 antibody. 
In addition to rapid, one-step purification, IMAC also offers the advantage of high 
capacity. However, one limitation of standard IMAC methods is the inability to purify 
His-tagged proteins directly from a source containing free metal ions, which interfere 
with the binding of the protein to immobilized metal-ion resins such as Cu
2+
. This is the 
case in the copper-inducible Drosophila S2 system where the recombinant protein 
accumulates in the conditioned medium which still contains free copper ions or, even 
worse, some copper remains bound to the His-tag, resulting in a low yield of purified 
protein. 
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One method that overcomes with this disadvantage is the use of the Chelating Sepharose 
Fast Flow resin (GE Healthcare). This resin consists of iminodiacetic groups coupled to 
sepharose able to form complexes with transition metal ions such as Cu
2+
, therefore, 
selectively retaining proteins with exposed histidine residues present in the medium (Lehr 
et al., 2000). 
Three days after induction, the conditioned medium was collected and cleared by 
centrifugation at 3000xg for 10 minutes at 4°C. Binding to the resin was performed 
batchwise (1 ml resin/L medium, enough to bind approximately 5 mg His-tagged protein) 
overnight at 4°C under rotation. The resin-Cu
2+
-protein slurry was then poured into a 
column and attached to the BioRad Econo System device (BioRad) to facilitate the 
forthcoming steps. Washing was performed sequentially at a rate of 0.5 ml/min with PBS 
until baseline UV absorbance monitored at 280 nm and then again with 10 mM imidazole 
in 0.5 M/PBS to remove non-specifically bound proteins. Competitive elution of the 
desired protein was carried out with 250 mM imidazole in 50 mM Tris pH 8.0. Elution 
fractions were collected in 0.5 ml aliquots and analysed by SDS-PAGE (see section 
II.2.2.2). Finally, the column was stripped with 20 mM EDTA in PBS to remove any 
metal bound to the resin and re-equilibrated with 50 vol of deionized water. 
Positive elution fractions were pooled, dialysed overnight against PBS at 4°C and stored 
in aliquots at -20°C. Freezing/thawing cycles were always avoided. Protein concentration 
of the samples was assessed by a modified Lowry method (see section II.2.2.4) 
 
II.2.2.2 SDS-PAGE 
 
Protein purification and characterization was assessed by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) under reducing conditions. The strongly anionic detergent 
SDS is used in combination with a reducing agent (e.g. β-mercaptoethanol) and heat to 
dissociate the proteins before they are loaded onto the gel. The denatured polypeptides 
bind SDS and all become negatively charged in a sequence-independent fashion, thus 
allowing the proteins to migrate according to their size. Therefore, by using markers of 
known molecular weight, it is possible to estimate the molecular size of the polypeptide 
of interest.  
The most common SDS-PAGE is carried out with a discontinuous buffer system 
(Ornstein and Davis, 1964) in which the buffer in the reservoir is of a pH and ionic 
strength different from that of the buffer used to cast the gel, and all the components of 
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the system contain 0,1% SDS (Laemmli, 1970). The SDS-polypeptide complexes are 
swept along by a moving boundary created when an electric current is passed between the 
electrodes. After migrating through a “stacking gel” of high porosity, the complexes are 
deposited in a very thin zone on the surface of the “resolving gel”, through which they 
will be resolved according to their size. 
In this work, 30 μl of each sample were diluted in 2x SDS gel loading buffer (with or 
without a reducing agent) and denatured by heating at 95°C for 5 minutes before being 
loaded onto a polyacrylamide (PAA) gel. Gels were run in Laemmli buffer at 25 mA in 
the stacking gel and 45 mA in the resolving gel.  
 Stacking gel 
(5%) 
Resolving gel 
(12,5%) 
Rotiphorese Gel 30                  
(30% Acrylamide, 0.8% Bisacrylamide) 
0.85 ml 6.25 ml 
1.5 M Tris buffer pH 8.8 --- 3.75 ml 
0.5 M Tris buffer pH 6.8 1.5 ml --- 
Deionized water 3.75 ml 5 ml 
10% SDS 60 μl 150 μl 
N,N,N’,N’-Tetramethylethylendiamin (TEMED) 5 μl 10 μl 
10% Ammoniumpersulphate (APS) 50 μl 100 μl 
Table 5.  Composition of a 12.5% PAA-gel 
 
II.2.2.3 Coomassie staining and drying of PAA-gels 
 
In order to visualise protein bands on the polyacrylamide gel or a Western Blot 
membrane, they were stained with coomassie blue. For this, membranes or gels were 
soaked in the staining solution for some minutes and further decoloured in destaining 
solution until the background was clear enough and the protein bands sharp visible. For 
long term storage of the gels, they were intensively washed with water and dried in the 
BIO RAD SLAB DRYER (Model 483). 
 
II.2.2.4 Determination of protein concentration 
 
The amount of protein in the elution fractions was measured with the BCA™ Protein 
Assay Kit (Pierce). This is a colorimetric assay for protein concentration following 
detergent solubilization. As with the known Lowry assay, there are two steps which lead 
to colour development: the reaction of the protein and copper in an alkaline medium and 
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the subsequent reduction of Cu
2+
 to Cu
1+
 reagent by the copper-treated protein. Colour 
development is primarily due to the amino acids tyrosine and tryptophan. Proteins induce 
a reduction of reagent by containing bicinchonicic acid (BCA). The purple-coloured 
reaction product of this assay is a formed by chelation of two molecules of BCA with the 
cuprous ion. This water soluble complex exhibits a strong absorbance at 562 nm, 
respectively.  
Ficolin concentration was determined according to the manufacture’s instructions.  
II.2.3 Labelling of Ficolins 
 
Recombinant ficolins used for the bacterial screening were directly labelled either with 
biotin or with Cy5 dye.  
 
II.2.3.1 Biotinylation 
 
The biotinylation of recombinant ficolins was performed according to the manufacture’s 
instructions of the Pierce EZ-Link® NHS-PEO Solid Phase Biotinylation Kit. 
Briefly, this method uses SwellGel® Nickel Chelated Disks composed of a dehydrated 
nickel-chelated agarose resin to first immobilize purified ficolins. The proteins are then 
biotinylated by adding a solution of NHS-PEO4-Biotin. Excess biotin is washed from the 
column, and the ficolins are eluted in the buffered imidazole solution. NHS-PEO4-
Biotinreacts with primary amines, primary ε-amine groups on available lysine residues. 
Afterwards SwellGel® Disk must be placed in the bottom of a 1.5 ml microcentrifuge 
tube and Ficolin A or B Binding Solution must be added to the tube. After 30 min of 
incubation the column was centrifuged and the pellet was washed three times with 1 ml 
PBS. Other 0.3 ml of PBS was added to the pellet and the resin was resuspended gently. 
The entire volume was pipetted into resin column. After the centrifugation of the column 
the flow-through was discarded, the column was plugged from the bottom.  The contents 
of a One No-Weigh NHS-PEO4-Biotin Microtube was diluted in 0.2 ml of PBS and 
added to the amount of ficolin directly to the column. The biotinylation reaction was 
incubated for 30 min. After the column was washed with 0.4 ml of PBS three times,  
Elution Buffer was added to elute the bound biotinylated ficolins from the column. The 
biotinylated ficolins were stored at 4 C.  
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II.2.3.2 Cy5-labelling 
 
The Cy5 Ab Labelling Kit (Amersham Biosciences) was used according to the 
manufacturing instructions. Cy5 is a cyanine reagent and has been shown to be useful as 
a fluorescent label, which produces an intense signal in the far red region of the spectrum. 
1 mg of purified recombinant ficolins was dissolved at 1mg/ml in 50mM of PBS and 
mixed with coupling buffer and tranfered to the vial of reactive dye. The reaction was 
incubated at the room temperature for 30 minutes with additional mixing every 10 
minutes. The ficolin-labelling mixture then was transferred to the top of a mini-spin 
column and allowed to enter the packet. The addition of 2 ml of elution buffer allowed a 
faster moving blue band of labelled ficolin to be separated from the free dye. Labelled 
ficolins were collected in clean tubes and stored at 4˚C avoiding direct light contact. 
II.2.4 Bacteriological procedures 
II.2.4.1 Fixation of bacteria 
The bacterial strains used for the binding screening were kindly provided  by Dr. Stefen 
Thiel co-workers (University of Aarhus, Denmark). S. pneumoniae serotypes 1, 4, 14, 
6A, 6B, 7A, 7F, 9L, 9V, 11A, 11B, 11C, 11D, 11F, 19C, 19F, 23F, 27, 32F, and 45 and 
the non-capsulated variant strain SCR2 (Statens Serum Institut, Copenhagen, Denmark) 
were grown in Todd-Hewitt broth medium (Oxoid, Basingstoke, England) overnight at 
37°C in 5% CO2. S. aureus serotypes 1 to 13 (T1 to T13) and the non-capsulated variant 
strain Wood (National Institutes of Health, Bethesda, Md.) were cultured on Columbia 
agar plates (Difco, Kansas City, Kans) supplemented with 1% (wt/vol) yeast extract and 
0.1% (wt/vol) glucose at 37°C overnight to ensure maximum production of capsules (4, 
9, 16, 29). E. coli was grown in Luria-Bertani broth (Q-Biogene, Carlsbad, Calif.) 
overnight at 37°C. In order to fix the cells formaldehyde (Sigma-Aldrich, St. Louis, Mo.) 
was added to the broth cultures to a final concentration of 1% (wt/vol), and the cultures 
were kept at room temperature until the next day. This treatment stabilizes the cells but 
does not alter the polysaccharide antigens. S. aureus organisms were washed off the agar 
plates, resuspended in 5 ml of PBS, and fixed with formaldehyde as described above. 
Residual reactive aldehyde groups were blocked by incubation with a 1/10 volume of 1M 
ethanolamine (pH 9.0) for 1 hour. The bacterial cells were then washed three times with 
TBS and stored at 4°C. The bacterial concentration (BC) was estimated by reading the 
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optical density (OD) at 600 nm (Eppendorf Bio Photometer 6131) and considering that an 
optical density of 1.0 corresponds to approximately 1.8 ×10
9
 bacteria/ml. 
BC = OD x DF x 1.8x10
8 
 CFU/mL. 
 
II.2.4.2 Bacterial screening for ficolin A and B binding by flow cytometry 
 
Stabilized bacterial cells (1.5×10
8) were incubated with 6 μl of biotinylated or Cy5 
conjugated ficolin in a total volume of 400 μl of TBS/Tw/Ca (see section II.1.6) for 2 h at 
room temperature with end-over-end rotation. 
Samples were centrifuged, and the pellets were washed three times with 1 ml of 
TBS/Tw/Ca, resuspended in the same buffer. Whenever biotinylated ficolins were used, 
the cells were then incubated at room temperature for 1 hour with 6 μg of fluorescein 
isothiocyanate (FITC)-labeled streptavidin. Bacterial cells were washed three times, 
resuspended in 200 μl of TBS/Tw/Ca, and subtected to flow cytometry using a FACS 
LSRII flow cytometer (BD Biosciences, San Jose, California).  
 
II.2.4.3 Competitive assay 
II.2.4.3.1 Competitive assay between labelled and unlabelled ficolins 
 
In order to confirm that the screening results were not due to artefact and that the 
bacteria-ficolin binding was specific, competitive assays with unlabeled ficolins were 
performed. 
For this the bacterial strains which showed positive results in the binding screening were 
pre-incubated with unlabeled ficolin A or B for two hours at room temperature and 
intensively washed before being subjected to the binding screening as described above 
(see section II.2.4.2) and analysed by flow cytometry. 
 
II.2.4.3.2 Competitive assays between ficolin A and B 
 
In order to test if ficolin A and B compete for binding to the same cell, competitive 
assays with both mouse ficolins were performed. For this the bacterial strains Str. 
pneumoniae serotype 23F and serotype 1were pre-incubated with unlabelled 1) ficolin A 
or 2) ficolin B for two hours at room temperature. After intensive washing the cells were 
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further subjected to the binding screening procedure (see section II.2.4.2) with either 
labelled 1) ficolin B or 2) ficolin A, and analysed by flow cytometry. 
 
II.2.4.4 Calcium and Sodium requirement 
 
In order to test if the binding of mouse ficolins to bacterial strains requires the presence 
of calcium ions to stabilize the complexes, the binding screening was repeated with the 
staphylococcal strain (serotype 5) and streptococcal strains (serotype 21) under different 
salt conditions. Cells were incubated with labelled ficolins either in the presence or 
absence (EDTA-TBS) of calcium and increasing concentrations of sodium chloride 
(NaCl) raging from 31,25 mM to 1M. 
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III. Results 
 
Ficolin-A and -B are pattern recognition molecules of the mouse innate immune system. 
Assuming that these recognition molecules bind to different microorganisms, we 
compared the reactivities of ficolin-A and -B with the opportunistic mammalian 
pathogens Staphylococcus aureus, Streptococcus pneumoniae as well as with strains of 
Escherichia coli and with the fungus Candida albicans. By testing different strains we 
investigated the ability of ficolins to bind to capsulated and non-capsulated bacterial 
cells. The various bacterial serotypes were incubated with purified biotinylated ficolin-A 
or -B followed by FITC-labeled streptavidin. Screening by flow cytometry of S. aureus, 
Str. pneumoniae, E. coli and Candida albicans revealed an overlapping but not identical 
binding of ficolin-A and -B. 
In this work the binding affinity of a ficolin-A or -B to a bacterial strain less than 20% is 
considered as negative. Figures show the binding affinities of ficolins. “Not-binding” 
means that the flow cytometry of the the ficolin after incubation with bacteria is similar 
to the autofluorescence curve or shifted to the left. “Binding” means that the flow 
cytometry of the the ficolin after incubation with bacteria is similar shifted to the right 
from the autofluorescence curve. The more is the shift to the right the stronger is the 
binding. 
III.1  Staphylococcus aureus 
 
We investigated the binding ability of murine ficolins to 13 S. aureus strains and detected 
that ficolin-A and -B bind to different strains of S. aureus with variable affinity. S. aureus 
serotypes 1 – 12 are capsulated strains, while S. aureus Wood is non-capsulated. Figures 
5 – 17 show the results of the binding screening with S. aureus. Ficolin-A and -B bound 
to some S. aureus strains T4, T5, Wood. However, the most efficient binding was 
detected to the non-capsulated variant (Wood). But neither ficolin A nor ficolin B bound 
to the staphylococcal serotypes T6, T8, T9 and T10. Table 5 summarizes the results 
obtained from the screening. 
These results indicate that mouse ficolins recognize structures present in both capsulated 
and non-capsulated bacteria, suggesting that ficolins bind either to molecule present in 
both serotypes or that they recognize different antigens on these strains. The observed 
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binding to strain Wood may be caused by peptidoglycan in the staphylococcal cell wall 
consisting of alternating 1,4-beta-linked subunits of GlcNAc and N-acetylmuramic acid.  
 
S. aureus serotype or strain Binding (%)* 
 ficolin-A, % ficolin-B, % 
T-1 30 38 
T-2 15 30 
T-3 39 35 
T-4 80 72 
T-5 60,5 71 
T-6 8 5 
T-7 28 30 
T-8 13 8.9 
T-9 8 15 
T-10 10 9 
T-11 20 10 
T-12 20 30 
Wood 74.5 77 
Table 6.  Binding of ficolin-A and –B to different S. aureus strains. (*) Binding percentage of 
capsulated as non-capsulated bacterial cells. 
 
 
 
Figure 6. Both ficolin A and B bind to S. aureus serotype T-1 with the same affinity. A) Dot plot or the 
gated population of S. aureus serotype T-1 and B) Binding of ficolin A and B was measured by flow 
cytometry after incubation with bacteria and expressed the results shown in 3 to 5 independent 
experiments. 
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Figure 5. Ficolin B but not ficolin A binds to S. aureus serotype T-2. Dot plot or the gated population of 
S. aureus serotype T-2 and B) Binding of ficolin A and ficolin  B was measured by flow cytometry after 
incubation with bacteria and expressed the results shown in 3 to 5 independent experiments. 
 
Figure 6. Both ficolins A or B show minimal binding to S. aureus serotype T 3. Dot plot or the gated 
population of S. aureus serotype T-3 and B) Binding of ficolin A and ficolin B was measured by flow 
cytometry after incubation with bacteria and expressed the results shown in 3 to 5 independent 
experiments. 
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Figure 7. Ficolins A or B bind to S. aureus serotype T-4 with different affinity. While ficolin B shows 
almost total recognition (96%), ficolin A binding was achieved only to a certain extent (15%). Ficolin B 
does not bind equally to S. aureus serotype 4. Ficolin A (15%) binds with a lower intensity than ficolin B 
(96%). Dot plot or the gated population of S. aureus serotype T-4 and B) Binding of ficolin A and B was 
measured by flow cytometry after incubation with bacteria and expressed the results shown in 3 to 5 
independent experiments. 
 
 
Figure 8. Both ficolin A and B bind to S. aureus serotype T-5 with same affinity. A) Dot plot or the 
gated population of S. aureus serotype T-5 and B) Binding of ficolin A and B was measured by flow 
cytometry after incubation with bacteria and expressed the results shown in 3 to 5 independent experiments.
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Figure 9.  Neither ficolin A nor ficolin B bind to S. aureus serotype T-6. Dot plot or the gated 
population of S. aureus serotype T-6 and B) Binding of ficolin A and B was measured by flow cytometry 
after incubation with bacteria and expressed the results shown in 3 to 5 independent experiments. 
 
 
Figure 10. Neither ficolin A nor ficolin B bind to S. aureus serotype T-7. Dot plot or the gated 
population of S. aureus serotype T-7 and B) Binding of ficolin A and B was measured by flow cytometry 
after incubation with bacteria and expressed the results shown in 3 to 5 independent experiments. 
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Figure 11.  Neither ficolin A nor ficolin B bind to S. aureus serotype T-8. Dot plot or the gated 
population of S. aureus serotype T-8 and B) Binding of ficolin A and B was measured by flow cytometry 
after incubation with bacteria and expressed the results shown in 3 to 5 independent experiments. 
 
Figure 12. Neither ficolin A nor ficolin B bind to S. aureus serotype T-9. Dot plot or the gated 
population of S. aureus serotype T-9 and B) Binding of ficolin A and B was measured by flow cytometry 
after incubation with bacteria and expressed the results shown in 3 to 5 independent experiments. 
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Figure 13.  Neither ficolin A nor ficolin B bind to S. aureus serotype T-10. Dot plot or the gated 
population of S. aureus serotype T-10 and B) Binding of ficolin A and B was measured by flow cytometry 
after incubation with bacteria and expressed the results shown in 3 to 5 independent experiments. 
 
Figure 14.  Neither ficolin A nor ficolin B bind to S. aureus serotype T-11. Dot plot or the gated 
population of S. aureus serotype T-11 and B) Binding of ficolin A and B was measured by flow cytometry 
after incubation with bacteria and expressed the results shown in 3 to 5 independent experiments. 
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Figure 15.  Neither ficolin A nor ficolin B bind to S. aureus serotype T-12. Dot plot or the gated 
population of S. aureus serotype T-12 and B) Binding of ficolin A and B was measured by flow cytometry 
after incubation with bacteria and expressed the results shown in 3 to 5 independent experiments. 
 
Figure 16. Both ficolin A and B bind to S. aureus serotype Wood with the same affinity. Dot plot or 
the gated population of S. aureus serotype Wood and B) Binding of ficolin A and B was measured by flow 
cytometry after incubation with bacteria and expressed the results shown in 3 to 5 independent 
experiments. 
 
III.2  Streptococcus pneumonia 
 
We tested the binding ability of murine ficolins to 18 Str. pneumoniae strains and found 
that ficolin-A and -B bind to different strains with variable affinity.  
Figures 18 – 34 show the results of the binding screening with Str. pneumoniae. Ficolin 
A bound to Str. pneumoniae strains SCR2, 7A, 27, 1, 11D with affinities over 70%. The 
most efficient binding of ficolin B (over 70%) was detected to Str. pneumoniae strains 
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14, SCR2, 27, 6A, 1, 11F, 11D. Very low binding was observed by the strains 45, 9VL, 
and 19C. Table 2 summarizes the results obtained from the screening. 
Str. pneumoniae serotype % of binding* 
Ficolin-A Ficolin-B 
SCR2 75 73 
TIGR4 13 14 
1 85.5 81 
6A 56 70.5 
6B 53 53 
7A 79 20 
7F 44 40 
9F 2.5 15 
9L 18 19 
9V 17 13 
11D 77 78 
11F 30 76 
14 69 72 
19C  8 6 
23F 55 50 
27 81 82 
32F 43 11 
45 Neg. 12.3 
Table 7. Binding of ficolin-A and –B to different Str. pneumoniae strains. (*) Binding percentage of 
capsulated as non-capsulated bacterial cells. 
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Figure 17. Both ficolin A and B bind to Str. pneumoniae serotype 14 with comparable affinity. A) Dot 
plot and gated population of Str. pneumoniae serotype 14. B) Binding of ficolin A and B was measured by 
flow cytometry after incubation with bacteria and expressed at the mean fluorescent intensity. The results 
shown in 3 to 5 independent experiments. 
 
 
 
Figure 18. Both ficolin A and B bind to Str. pneumoniae serotype SCR2 with same affinity. A) Dot 
plot and the gated population of Str. pneumoniae serotype. B) Binding of ficolin A and B was measured by 
flow cytometry after incubation with bacteria and expressed at the mean fluorescent intensity. The results 
shown in 3 to 5 independent experiments. 
 
 
 
 
 
BA
40
Autofuorescence
Ficolin A
Ficolin B
c
o
u
n
ts
c
o
u
n
ts
40
c
o
u
n
ts
Autofuorescence
Ficolin A
Ficolin B
BA
100                      101 102 103 104
c
o
u
n
ts
   Results 
50 
 
 
Figure 19.  Ficolin A but not ficolin B bind to Str. pneumoniae serotype 7a.  While ficolin A shows high 
affinity (80%) to Str. pneumoniae serotype 7a, ficolin B binding was not achieved to signicant extent (less 
than 20%). A) Dot blot and gated population of Str. pneumoniae serotype 7. B) Binding of ficolin A and B 
was measured by flow cytometry after incubation with bacteria and expressed at the mean fluorescent 
intensity. The results shown in 3 to 5 independent experiments. 
 
 
 
Figure 20.  Both ficolin A and B bind to Str. pneumoniae serotype 27 with same affinity. A) Dot plot 
and the gated population of Str. pneumoniae serotype. B) Binding of ficolin A and B was measured by flow 
cytometry after incubation with bacteria and expressed at the mean fluorescent intensity. The results shown 
in 3 to 5 independent experiments. 
 
 
 
60
c
o
u
n
ts
Autofuorescence
Ficolin A
Ficolin B
BA
100                         101 102 103 104
c
o
u
n
ts
40
c
o
u
n
ts
Autofuorescence
Ficolin A
Ficolin B
BA
100                  101 102 103 104
c
o
u
n
ts
   Results 
51 
 
 
Figure 21. Both ficolin A and B bind to Str. pneumoniae serotype 6A. A) Dot plot and the gated 
population of Str. pneumoniae serotype 6A. B) Binding of ficolin A and B was measured by flow 
cytometry after incubation with bacteria and expressed at the mean fluorescent intensity. The results shown 
in 3 to 5 independent experiments. 
 
 
Figure 22. Both ficolins A or B show partial binding to Str. pneumoniae serotype TIGR4. A) Dot plot 
or the gated population of Str. pneumoniae serotype TIGR4 and B) Binding of ficolin A and B was 
measured by flow cytometry after incubation with bacteria and expressed the results shown in 3 to 5 
independent experiments. 
 
40
c
o
u
n
ts
Autofuorescence
Ficolin A
Ficolin B
BA
100                       101 102 103 104
c
o
u
n
ts
40
c
o
u
n
ts
Autofuorescence
Ficolin A
Ficolin B
BA
100                             101 102 103 104
c
o
u
n
ts
   Results 
52 
 
 
Figure 23. Both ficolins A or B show minimal binding to Str. pneumoniae serotype 9L. Dot plot and the 
gated population of S. aureus serotype 1. B) Binding of ficolin A and B was measured by flow cytometry 
after incubation with bacteria and expressed at the mean fluorescent intensity. The results shown in 3 to 5 
independent experiments. 
 
 
 
Figure 24. Both ficolin A and B bind to Str. pneumoniae serotype 6B with comparable affinity. A) Dot 
plot and the gated population of Str. pneumoniae serotype 6B. B) Binding of ficolin A and B was measured 
by flow cytometry after incubation with bacteria and expressed at the mean fluorescent intensity. The 
results shown in 3 to 5 independent experiments. 
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Figure 25. Neither ficolin A nor ficolin B bind to Str. pneumoniae serotype 19C. A) Dot plot and the gated 
population of Str. pneumoniae serotype 19C. B) Binding of ficolin A and B was measured by flow cytometry 
after incubation with bacteria and expressed at the mean fluorescent intensity. The results shown in 3 to 5 
independent experiments. 
 
 
Figure 26. Neither ficolin A nor ficolin B bind significantly to Str. pneumoniae serotype 9F. A) Dot 
plot or the gated population of Str. pneumoniae serotype 19F and B) Binding of ficolin A and B was 
measured by flow cytometry after incubation with bacteria and expressed the results shown in 3 to 5 
independent experiments. 
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Figure 27. Ficolin A and B bind to Str. pneumoniae serotype 32F with different affinity While ficolin 
B does not show significant binding to Str. pneumoniae serotype 32F, ficolin A binds to a certain 
extent (43 %). A) Dot plot and the gated population of Str. pneumoniae serotype 32F and. B) Binding of 
ficolin A and B was measured by flow cytometry after incubation with bacteria and expressed at the mean 
fluorescent intensity. The results shown in 3 to 5 independent experiments. 
 
 
Figure 28. Both ficolin A and B bind to Str. pneumoniae serotype 23F with the same affinity. A) Dot 
plot and the gated population of Str. pneumoniae serotype 23F. B) Binding of ficolin A and B was 
measured by flow cytometry after incubation with bacteria and expressed at the mean fluorescent intensity. 
The results shown in 3 to 5 independent experiments. 
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Figure 29. Both ficolin A and B bind to Str. pneumoniae serotype 7F with the same affinity. A) Dot 
plot and the gated population of Str. pneumoniae serotype 7F. B) Binding of ficolin A and B was measured 
by flow cytometry after incubation with bacteria and expressed at the mean fluorescent intensity. The 
results shown in 3 to 5 independent experiments. 
 
 
 
 
Figure 30.  Both Ficolin A and B bind to Str. pneumoniae serotype 11F with different avidity. While 
ficolin B shows high recognition (76%) to Str. pneumoniae serotype 11F, ficolin B binding was achieved 
only to 30%. A) Dot plot and the gated population of S. aureus serotype 1. B) Binding of ficolin A and B 
was measured by flow cytometry after incubation with bacteria and expressed at the mean fluorescent 
intensity. The results shown in 3 to 5 independent experiments. 
 
 
40
c
o
u
n
ts
Autofuorescence
Ficolin A
Ficolin B
BA
100                         101 102 103 104
c
o
u
n
ts
45
c
o
u
n
ts
Autofuorescence
Ficolin A
Ficolin BBA
100                           101 102 103 104
c
o
u
n
ts
   Results 
56 
 
 
Figure 31. Both ficolin A and B bind to Str. pneumoniae serotype 1 with comparable affinity. A) Dot 
plot and the gated population of Str. pneumoniae serotype 1. B) Binding of ficolin A and B was measured 
by flow cytometry after incubation with bacteria and expressed at the mean fluorescent intensity. The 
results shown in 3 to 5 independent experiments. 
 
 
Figure 32. Minimal binding to Str. pneumoniae serotype 9V. A) Dot plot and the gated population of 
Str. pneumoniae serotype 19V. B) Binding of ficolin A and B was measured by flow cytometry after 
incubation with bacteria and expressed at the mean fluorescent intensity. The results shown in 3 to 5 
independent experiments. 
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Figure 33. Both ficolin A and B bind to Str. pneumoniae serotype 11D with the same affinity. A) Dot 
plot and the gated population of Str. pneumoniae serotype 11D. B) Binding of ficolin A and B was 
measured by flow cytometry after incubation with bacteria and expressed at the mean fluorescent intensity. 
The results shown in 3 to 5 independent experiments. 
 
III.3  Escherichia coli 
 
E.coli belongs to the group of enterobacteriaceae. Enterobacteriaceae are all gram-
negative and encapsulated, which contain lipopolisaccharide (LPS) in their envelope. In 
order to test whether immune ficolins are specific pattern recognition molecules for 
Gram-positive bacteria or are also able to recognize Gram-negative cells. Test of binding 
to E.coli was also included to this study and found to be negative. 
 
Figure 34. Neither ficolin A nor ficolin B bind to E. coli. A) Dot plot or the gated population of E. coli 
and B) Binding of ficolin A and B was measured by flow cytometry after incubation with bacteria and 
expressed the results shown in 3 to 5 independent experiments. 
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III.4 Calcium requirement of mouse ficolin B 
 
In this work it was investigated whether ficolins bind to bacterial surfaces in a calcium 
dependent manner. In particular, the ability of ficolin B to bind to S. aureus serotype 5 
and S. pneumonia serotype 21 was examined at increasing salt concentrations in the 
presence or absence of calcium. Equation 1 shows that ficolin B binding to both bacterial 
strains is absolutely calcium dependent since no binding was detected in the presence of 
EDTA. Furthermore, this calcium requirement was not affected by increasing salt 
conditions.  
 
Equation 1.  Ficolin B binding to bacterial cells is calcium dependent. Ficolin B binds to S. aureus 
serotype 5 (bold lines) in the presence (filled dots) but not in its absence of calcium (open squares) 
independently of the NaCl concentration. The same is true for Str. pneumoniae (dotted lines). 
 
III.5 Competitive Assay 
 
In order to confirm that the screening procedure shows specific ficolin binding, 
competitive assays were performed where first unlabelled ficolin molecule blocks the 
binding sites and consequently can not be recognized by the same Cy5-labeled ficolin 
any more (the graphic results are not shown). All the bacterial strains which were positive 
for ficolin binding were tested in this way. 
Ca
2+
-requirement for ficolin-B binding
0
10
20
30
40
50
60
70
80
90
100
0 200 400 600 800 1000 1200
NaCl (mM)
%
 B
in
d
in
g
   Results 
59 
 
One strain of S. aureus and one strain of Str. pneumonia positive for both ficolin A and B 
binding, did not bind anymore after the bacteria had been pre-incubated with unlabeled 
ficolins.  
In order to test whether ficolin A and B compete for the binding on the same bacterial 
strains, competitive assays were also performed by pre-incubating the bacteria with 
unlabelled ficolin A or B followed by incubation with Cy5-labelled ficolin B and A. 
Several bacterial strains were tested in this way and the results indicate that competition 
between mouse ficolins for the binding to the same ligand does occur only with certain 
bacterial strains. For example, the binding of labeled ficolins A and B to Str. pneumonia 
serotype 27F is strongly affected by pre-incubating the cells with the other unlabeled 
ficolin. However this seems not to be the case of Str. pneumonia serotype 1, where the 
competition is only partial. 
III.6  Candida albicans 
 
In our experiments we wanted to test whether ficolins bind to C. albicans. Like in the 
bacterial screening, fungal cells were incubated with fluorescently labeled ficolin A or B 
and binding measured by flow cytometry. Fluorescent intensities were measured by flow 
cytometry and no binding was found (Figure 1). 
 
 
Figure 35. Neither ficolin A nor ficolin B bind to C. albicans. A) Dot plot or the gated population of C. 
albicans and B) Binding of ficolin A and B was measured by flow cytometry after incubation with bacteria 
and expressed the results shown in 3 to 5 independent experiments. 
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IV. Discussion 
IV.1 Binding studies 
 
The efficient elimination of bacteria requires the cooperation of multiple mechanisms 
from the innate and the adaptive immune system. The complement system is a protein 
cascade, capable of neutralizing invading pathogens. One of its activation pathways is the 
lectin pathway which is dependent on the binding of MBL or ficolins to the pathogens. 
Ficolins form a class of pattern recognition receptors that bind specifically to 
carbohydrate moieties on microbial surfaces and provide the front line defense against 
infection. However, the specificity of mouse ficolin recognition remains uncertain despite 
studies which showed these proteins may have a common carbohydrate binding 
specificity to N-acetylglucosamine (Matsushita et al., 1996). In this work the potential of 
mouse ficolins A and B to adhere to various strains of capsulated and non-capsulated 
bacteria was examined in screening assays. Seventeen of the most common serotypes of 
Str. pneumonia and twelve known capsulated serotypes of S. aureus (T1 – T12) were 
used in these experiments. Relevant non-capsulated strains of S. aureus (Wood) and Str. 
pneumonia (SCR2 and TIGR4) were also included to examine the influence of 
capsulation on the binding recognition by mouse ficolins. No binding was detected of 
either mouse ficolin to E.coli and Candida albicans. 
The screening of S. aureus revealed that ficolin A and B bind to different strains with 
variable affinity: ficolin A and B bind to S. aureus strains T4, T5 and Wood with 
affinities over 70%. But neither ficolin A nor ficolin B bind to the staphylococcal 
serotypes T6, T8, T9 and T10. On the other hand, the screening of Str. pneumonia 
showed that both ficolins bind with a high affinity to pneumococcal strains 1, 11D, 14, 27 
and SCR2. However, comparing the binding activities of murine ficolins to the serotypes 
7A, 6A, 11F and 32F it becomes clear that, while one ficolin shows high bacterial 
recognition, the other ficolin achieved binding only to a very low extent. Ficolin A binds 
with a high affinity to the strains 7A and 32F, while ficolin B displays similar results with 
strains 6A and 11F.  
Those differences in bindings are considered statistically significant because we repeated 
the experiments from 3 to 5 times, our measurements were reproducible in the next 
setting of experiments and due to p-value of 0,1 % it is highly unlikely that our results 
occurred by chance.  
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We suspect that ficolins A and B might not always overlap but also display differential 
binding preferences to different bacterial surfaces.  In addition, no significant binding of 
ficolin A or B was observed to the pneumococcal serotypes 19C, 9L, 9V, 9F and 45. 
Interestingly, the results obtained with these staphylococcal and pneumococcal strains 
also indicate that mouse ficolins recognize structures present in both capsulated and non-
capsulated bacteria. 
 
The majority of the staphylococcal capsular polysaccharides is mostly uncharged or 
possesses negative charges. In this regard it is interesting to compare the similar 
polysaccharide structures of serotypes T5 (binding) and T8 (non-binding).  
Moreau reported the polysaccharide structure of S. aureus serotype T5 (binding) to be 
(Moreau M et al., 1990): 
[→4)-3-O-Ac-β-D-ManpNAcA-(1→4)-α-L-FucpNAc-(1→3)-β-D-FucpNAc-(→]n1 
Vann et al. haves shown in their studies that the structure of S. aureus in serotype T8 
(non-binding) is (Vann W et al., 1989):  
[→3)-4-O-Ac-β-ManpNAcA-(1→3)-α-FucpNAc-(1→3)-β-FucpNAc-(1→]n2 
On the one hand, S. aureus serotype T5 (binding) capsular polysaccharide is structurally 
similar to the one found on serotype T8 (non-binding). The two polysaccharides differ 
only in the kind of linkages between the sugars (1→4 in T5 and 1→3 in T8) and the sites 
of O-acetylation of the ManNAcA residues (on the third or fourth position in T5 and T8, 
respectively). However, only S. aureus serotype T5 was recognized by both mouse 
ficolins.  
On the other hand, structural studies on both S. aureus serotype T5 and T8 revealed that 
serotype T8 (non-binding) has a zwitterionic charged motif conferred by the negatively 
charged carboxyl group of N-acetylmannosaminuronic acid and free amino groups 
available on partially N-acetylated fucosamine residues, which not only provides 
resistance to phagocytosis but also directly modulates the host immune response to 
bacterial infection (Tzianabos et al., 2001).   
In addition, the impaired ficolin binding to S. aureus serotype T8 compared to serotype 
T5 could also be the result of steric hindrance: two linkages between the sugars or O-
acetylation of the ManNAcA residues (Krarup et al., 2008). However, this is unlikely 
                                                 
1
 ManNAc = N-acetylmannosamineuronic acid; FucNAc = N-acetylfucosamine; p = pyranosidic; Ac = 
acetylgroup. 
2
 ManNAcA = N-acetylmannosamineuronic acid; FucNAc = N-acetylfucosamine; p = pyranosidic; Ac 
= acetylgroup.  
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since the saccharides are bound to the surface through a spacer; but the possibility could 
not be eliminated in the present work.   
 
Mouse ficolins show high binding affinity to the capsulated streptococcal strains 1, 11D, 
14, 27. 
The capsular polysaccharide of Str. pneumonia serotype 1 (binding) consists of the 
following repeating trisaccharide units (Jennings H.I. et al., 1980), (Stroop C. et al., 
2002): 
→4)-α-GalpA-(1→3)-α-GalpA-(1→3)-α-6dGalpNAc4N-(1→3 
 Schule and Ziegler describe the repeating unit of the immunodominant capsular 
polysaccharide of Str. pneumoniae serotype 27 (binding) as the synthesis of the 5-
aminopentyl glycoside tetrasaccharide:  
β-D-Glcp-(1→3)-4,6-carboxyethylidene-β-D-GlcNAcP-(1→3)-α-D-Galp-(1→4)-β-L-Rhap (Szu 
S.C. et al., 2005).
4
 
 Marc Kolkman and colleagues reported the chemical structure of the capsular 
polysaccharide of Str. pneumoniae serotype 14 (binding). It is composed of repeating 
units, with monosaccharide side chains of β-D-Galp-(1→ linked to C4 of each N-
acetylglucosamine residue. 
→6)-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-β-D-Glcp-(1→ (Kolkman M.A. et al., 
1997).
5
 
All these serotypes include similar molecular structures in their capsules: N-acetylgroups 
and 1,3-β-D-glucans. Previous studies have shown that mouse ficolins have an affinity 
for N-acetylated compounds (Matsushita et al., 1996). This motif likely plays an 
important part, but the presence of such N-acetylated carbohydrates in the capsules of Str. 
pneumonia serotypes did not always lead to binding. It could be possible that ficolins A 
and B recognize any oligosaccharides containing N-acetylated compounds where the N-
acetyl groups may have to be in a specific conformation that has to be fulfilled to 
maximize the ficolin binding. The oligosaccharide of the capsule of Str. pneumonia 
                                                 
3
 GalA = galactouronic acid; Gal = galactose; 6dGalNAc4N = 2-acetamido-4-amino-2,4,6-tridexo-D-
galactose; p = pyranosidic. The polysaccharide also contains a non-stichometric amount of O-acetyl-
groups, the position of which has not been reported.  
 
4
 Gal = galactose; GlcNAc = N-Acetylglucosamin; Rha = rhamnose; p = pyranosidic; P = phosphate 
residue. 
 
5
 Glc = glucose; Gal = galactose; Rha = rhamnose; p = pyranosidic.  
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serotype 1 (binding) consists of 3 molecules, one of those is N-acetylated and has a 1,3- 
β-D-conformation. Likely ficolins A and B bind to every third molecule in the 
polysaccharide capsule. The oligosaccharide present in Str. pneumonia serotype 27 
consists of a phosphorylated saccharide with one N-acetylated 1,3-β-D-glucan molecule. 
In the oligosaccharide of Str. pneumonia serotype 14 there are 3 pyranosidic sugar 
molecules, one of them is N-acetylated and involved in a 1,3-β-D-linkage. The high 
binding potential may arise from the high density of N-acetyl groups, so that some of 
them are found in the same conformation to enable ficolins to bind.  
As expected, mouse ficolins A and B not always overlap but also display differential 
binding preferences. For example ficolin A binds with a high affinity to the strains 7A 
and 32F and ficolin B does so with strains 6A and 11F, while the opposite does not occur. 
Str. pneumoniae 7A (binding ficolin A) possesses a neutral polysaccharide whose 
hexasaccharide repeating unit contains two L-rhamnose residues and one residue each of  
D-glucose, D-galactose, 2-amino-2-desoxy-D-glucose and 2-amino-2-desoxy-D-
galactose. The amino sugar residues are N-acetylated and every such polysaccharide 
residue contains one O-acetyl group (Backman-Marklund I et al., 1990). As mentioned 
above, ficolin A binds to Str. pneumoniae 7A with an affinity of 79%, while Ficolin B 
does not (Backman-Marklund I et al., 1990), which is statistically significant and might 
speak for a fact that ficolin A tend to bind to N-acatylated sugar residues, which are also 
reach on additional O-acatyl group. 
 
Where: Glc = glucose; GlcA = glucuronic acid; Gal = galactose; Rha = rhamnose; Ac = 
acetyl-group; p = pyranosidic; GalpNAc = pyranosidic 2-acetamido-2-deoxygalactose; 
GalpNAc = pyranosidic 2-acetamido-2-deoxyglucose. 
Likewise, while ficolin B shows very low binding (11%) to Str. pneumoniae serotype 
32F, ficolin A binds to this strain with an affinity of 43%. The specific capsular 
polysaccharide of Str. pneumoniae serotype 32F is composed of tetrasaccharide repeating 
units with a phosphorylcholine group linked to the 3-position of the 4-substituted β-L-
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rhamnose residue. The same rhamnose molecule is, in addition, O-acetylated at the 2-
position (Karlsson C et al., 1998): 
6
 
 
  The capsular polysaccharide units of both of Str. pneumoniae 7A and 32F possess β-
D-glucose and β-L-rhamnose, which is O-acetylated on the second C-atom. Interestingly, 
the oligosaccharide molecule of Str. pneumoniae serotype 32A possesses two phosphate 
molecules, which charge the capsular polysaccharide negatively, which is not the case of 
the capsule molecule of Str. pneumonia serotype 7A, where instead some sugar residues 
are N-acetylated. This observation might suggest that the binding potential of ficolin A 
may not always arise from the high density of N-acetyl groups but that it can depend on 
the overall charge of the oligosaccharide. The presence of N-acetyl groups may affect the 
binding of ficolins by simply neutralizing the charge of the sugar amine group which, 
without the acetyl substitution, would appear protonated (Runza et al., 2008). In the same 
way, the presence of phosphate could also neutralize a positive charge or confer a 
negative charge to the oligosaccharides.  
On the other hand Str. pneumoniae serotypes 11F and 6A display different binding 
results: ficolin B binds significantly over 70% to both strains in comparison to ficolin A, 
which only binds to a certain extent (20-30%).  
The capsular polysaccharide of Str. pneumoniae serotype 11F is an unbranched linear 
polymer of a ribitol-phosphate substituted repeating tetrasaccharide unit composed of 2-
acetamino-2-deoxy-D-glucose (one part), D-glucose (one part), D-galactose (two parts), 
ribitol (one part), phosphate (one part), and O-acetyl (two parts) (Richards JC et al., 
1985). 
The capsular polysaccharide of serotype 6A (binding ficolin B) is a linear polymer with a 
repeating unit containing four monosaccharides: rhamnose, ribitol-phosphate, galactose 
                                                 
6
 Glc = glucose; Rha = rhamnose; p = pyranosidic; P = phosphate; PCho = phosphorylcholine 
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and glucose (Kamerling et al., 2000) with the following chemical structure (Ho Park et 
al., 2000):  
→2) α-D-Glcp-(1→3)-α-D-Glcp-(1→3)-β-D-Rhap-(1→3)-ribitol (5→P 7 
Comparing the capsular polysaccharides of Str. pneumonia serotype 6A and serotype 11F 
both of them include ribitol-phosphate, 1,3-β and 1,3-α-D-glucans and phosphate groups, 
while only serotype 11 F (binding ficolin B) includes one N-acatylated residue in its 
capsule.  
However the presence or absence of the acetyl group is not likely to determine binding of 
ficolin A, although its confirmation and/or density might.  
In general, both ficolins bind to strains that rich of α- and β-D-glucose, pyranosidic α-and 
β-D-N-acetylglucosamin or α-D-galactose residues in their capsides. Ficolin B binding 
was also observed with strains which possess ribitol-phosphate in their capsule structure 
and ficolin A with strains bearing pyranosidic β-D-glucose and acetylated β-L-rhamnose. 
This indicates, that the ficolin binding to bacterial surfaces can depend on different 
polysaccharide structures such as sugar molecules, their configuration and acetylation, 
phosphate groups and amount of particular polysaccharides in the polymer chain. 
 
No significant binding of mouse ficolins was observed to the capsulated pneumococcal 
serotypes 19C, 9L, 9V and 9F. The specific capsular polysaccharide produced by Str. 
pneumoniae type 9V is composed of D-glucuronic acid (1 part), 2-acetamido-2-deoxy-D-
mannose (1 part), D-glucose (2 parts), and O-acetyl (1.6 parts) in the following 
configuration (Perry et al., 1981; Rutherford et al., 1991)
8
: 
 
 The specific capsular polysaccharide produced by Streptococcus pneumonia serotype 9L 
(American type 49) is composed of D-galactose (one part), D-glucose (one part), D-
glucuronic acid (one part), 2-acetamido-2-deoxy-D-mannose (one part), and 2-acetamido-
2-deoxy-D-glucose (one part) in the following configuration (Rutherford et al., 1991)
9
: 
                                                 
7
 Glc = glucose; Rha = rhamnose; p = pyranosidic; P = phosphate. 
 
8
 Glc = glucose; GlcA = glucuronic acid; Gal = galactose; ManNAc = 2-acetamido-2-deoxymannose; OAc 
= O-acetyl. 
 
9
 Glc = glucose; GlcA = glucuronic acid; Gal = galactose; ManNAc, 2-acetamido-2-deoxymannose; OAc = 
O-acetyl; p = pyranosidic. 
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The polysaccharide structure of Str. pneumonia serotype 9F is composed of the following 
oligosaccharide (Beynon LM et al., 1991 and Morona JK et al., 1999)
10
: 
 
The serotype 19C is composed of repeating tetrasaccharide units as it follows pyranosidic 
(Beynon LM et al., 1991 and Morona JK et al., 1999)
11
: 
 
Interestingly, all these structures of capsular polysaccharide possess β-D-ManNAc. 
Capsular polysaccharides of serotypes 9V and 9L also include glucuronic acid, which 
imparts a positive charge to the polysaccharide chain. Due to the phosphate molecules the 
serotypes 19C and 19F is negatively charged. It seems that β-D-ManNAc molecules do 
not play a role in the binding of mouse ficolins to streptococcal polysaccharides, 
suggesting that the repertoire of microbial organisms recognized by mouse ficolin does 
not necessarily overlap to the one recognized by MBL (which binds to the mannan 
residues). At the same time although the strains 9V, 19C, 19F do not bear a GlcNAc 
molecules in their capsule, the strain 9L does, which could only be an evidence, that 
ficolins recognize GlcNAc residues only in a specific configuration (9L posses a GlcNAc 
molecule).  
 
Mouse ficolins also bind to non-capsulated S. aureus Wood and Str. pneumonia strains 
SCR2 (a non-capsulated variant of serotype 2) and TIGR2.  
Non-capsulated strains consist of phospholipid membrane, peptidoglycan, teichoic and 
lipoteichoic acids. The cell wall of gram positive bacteria includes a thick peptidoglycan 
                                                                                                                                            
 
10
 D-Glc = glucose; D-ManNAc = N-acetylmannosamine; L-Rha = rhamnose and all sugar molecules are 
pyranosidic. 
 
11
 D-Glc = glucose; D-ManNAc = N-acetylmannosamine; L-Rha = rhamnose; D-Rib = ribose and all sugar 
molecules are. 
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layer, which consists of three structural parts, such as glycan chains of a repeating 
disaccharide composed of N-acetylglucosamine and N-acetylmuramic acid, tetrapeptide 
chains and peptide bonds (Fig. A and B). 
A.  
 
B.  
 
Figure 36. A. Peptidoglycanstructure of gram-positive bacteria. B. Transpeptidation reaction as a final step 
of peptidoglycan synthesis (Rosenthal et al., 2007). 
 
The cell wall-associated teichoic and lipoteichoic acids of S. aureus Wood are composed 
of a linear backbone structure of 4-O-β- and 4-O-α-N-acetyl-D-glucosaminyl bridged by 
1,5-phosphodiester linkages. Approximately 50% of the ribitol residues are esterified at 
the C-2 position with D-alanine (Tzianabos et al., 2001).  
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According to the structure
 
of pneumococcal teichoic and lipoteichoic acids, the 
polysaccharide is comprised of several
 
repeating units, each of which starts with glucose 
and ends
 
with ribitol, with the lipid anchor predicted to be 
Glc(β1→3)AATGal(β1→3)Glc(α1→3)-acyl2Gro,
 
where AATGal is 2-acetamido-4-
amino-2,4,6-trideoxy-D-galactose (Ho Seong Seo et al., 2008).
 
The peptidoglycan 
scaffold of the pneumococcal cell wall
 
is a repeating GlcNAc-N-acetylmuramic 
(MurNAc) disaccharide
 
(GlcNAc-(β-1,4)-MurNAc) unit having a pentapeptide attached 
to
 
the D-lactyl moiety of each MurNAc unit (Loeffler et al., 2001). Another usual 
component of the pneumococcal cell wall is phosphorylcholine, which anchors choline-
binding proteins non-covalently to the cell wall (Bergmann S et al., 2006).  
Since the results obtained with capsulated bacterial strains suggest that mouse ficolins 
have an affinity towards α-configurated N-acetylated compounds this motif might also 
play an important role in the ficolin binding to peptidoglycan of non-capsulated gram-
positive bacterial strains. 
The experiments of the present work were done from three to five times independently 
and the measurements were reproducible in up to 92,3%. The results of the present work 
indicate with a significant difference that mouse ficolins recognize structures present in 
both capsulated and non-capsulated bacteria, suggesting that ficolins either bind to 
molecules exclusively present in both serotypes or that they recognize different antigens 
on these strains. The possibility that the bacterial cells of the same strain is always 
glycosylated in an identical fashion can be not completely excluded due to high 
possibility of the surface antigen mutation. However ficolins A and B might have a 
common binding affinity for 1,4-β-GlcNAc, α-N-acetylmuramic acid, α-D-Glcp, α-D-
GalNAc, β-D-Gal, because those sugar molecules are present on the bacterial strains 
recognized by mouse ficolins. Likewise β-D-glucose and β-L-rhamnose could be ligands 
for the binding of the ficolin A while ribitol-phosphate, α-D-Glucose and β-D-Galactose 
could be the target of mouse ficolin B. 
Mouse ficolins A and B are the orthologues of L- and M-ficolins in humans, respectively. 
However, they seem to recognize different pattern. The ability of human L-ficolin to bind 
to different serotypes and non-capsulated variants of S. aureus was investigated by other 
research groups. L-ficolin binds to some capsulated S. aureus serotypes (T1, T8, T9, T11 
and T12) but not to the non-capsulated strain Wood (Krarup et al., 2005). According to 
the results of this doctoral thesis none of the mouse ficolins binds with an affinity > 20% 
to any of these capsulated serotypes. The screening results of Krarup’s research group 
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show that the L-ficolin binds significantly to serotype T8 and does not show a high 
binding affinity to the serotype T5 (Krarup et al., 2005), which is exactly the opposite of 
the results obtained in the present work. 
In addition, Krarup and co-workers suggested the binding of L-ficolin to be directed 
towards the capsule (Krarup, et al., 2005), which is in opposition to another report that L-
ficolin binds to teichoic and lipoteichoic acids and protein A which are present on the 
non-capsulated bacterial surface  of E. coli (Lynch et al., 2004).  
Krarup and colleagues also investigated the ability of human L-ficolin to bind to different 
serotypes and non-capsulated variants of Str. pneumoniae, which were also included in 
this doctoral thesis. Like with S.aureus, L-ficolin binds to some capsulated Str. 
pneumoniae serotypes (serotypes 11A, 11D and 11F), but not to non-capsulated strains 
TIGR and SCR2 (Krarup et al., 2005). Again, mouse recombinant ficolins A and B 
showed a high binding affinity to both capsulated and non-capsulated streptococcal 
serotypes (serotypes 1, 11D, 14, 27, SCR2 and TIGR) (present work). 
This might indicate that ficolins of different species recognize different structures on 
bacteria. This is not surprising, given the fact that each different pathogen interacts with a 
different host species in different ways depending on the ability whenever it causes a 
disease in thiese organisms or not.     
 The results obtained in this doctoral thesis indicate that mouse ficolins have complex 
binding requirements to particular bacterial strains which are not necessarily the same for 
human ficolins for particular bacterial strains. Both human and mouse ficolins, recognize 
N-acetylated sugar patterns, however, the actual conformation and amount of particular 
sugar molecules in a polysaccharide unit might also play an important role in this 
recognition. It was not possible to determine which residues are essential for binding to 
bacterial cells by mouse ficolins but it seems likely that a single carbohydrate residue is 
not enough to allow for the mouse ficolin to bind. The screening indicates that mouse 
ficolins recognize binding motifs by multiple interaction sites per oligosaccharide. The 
fibrinogen-like domain of mouse ficolins might also coordinate and at the same time be 
affected by the N-acetyl and negative charged groups (Krarup et al., 2008). By having 
complex conformational requirements, mouse and human ficolins might be capable of 
recognizing microorganisms, which attempt to mask themselves with carbohydrates to in 
order to escape the immune systems. By doing so this might lead to opsonization and 
subsequent complement activation. 
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IV.2 Calcium requirement of mouse ficolin B 
 
Ficolins belong to the Ca
2+
-dependent (C-type) lectin super family and are characterized 
by the presence of a fibrinogen like (fbg) domain. Through this domain they bind to sugar 
residues on microbial surfaces in a calcium-dependent manner. The fbg-like domain in 
ficolins seems to be Ca
2+
-dependent, but there has been some controversy about it: 
Matsushita and colleagues compared amino acid sequences in the carbohydrate 
recognition domain (CRD) of MBL, which are responsible for calcium-dependent 
carbohydrate binding and fibrinogen-like domains of ficolins: there is no sequence 
homology between the CRD and the fbg-domain, but they discovered potential calcium-
binding sites within the fbg-domain (Matsushita et al., 1996).  
Le and colleagues investigated the calcium-dependence of ficolin binding and observed 
that its binding to GlcNAc was independent of activating the complement cascade (Le et 
al., 1997). In the most recent studies of Gout and colleagues on M-ficolin it was shown to 
bind PTX3 with high affinity in the presence of calcium ions. The interaction was 
abolished in the presence of EDTA and inhibited by N-acetyl-D-glucosamine, indicating 
involvement of the fibrinogen-like domain of M-ficolin (Gout et al., 2011). Considering 
this controversity it was investigated in this doctoral thesis whether ficolins bind to 
bacterial surfaces in a calcium dependent manner. As already mentioned in Results this 
calcium requirement was not affected by increasing salt conditions. In contrast, it was 
shown by Krarup and colleagues who reported the ability of L-ficolin to bind to bacterial 
surfaces in the absence of calcium at the high NaCl concentrations (Krarup et all, 2004). 
As these results demonstrate ficolin B requires calcium molecules to bind to bacterial 
surface molecules that ficolin B does not bind to pathogens in the absence of calcium 
ions. It could be that binding of mouse ficolins to bacterial surfaces has different 
requirements in presence or absence of calcium depending on the interaction between the 
ligands on the fbg domain and the bacterial surfaces.  
    
IV.3 Competitive Assay 
 
As we recon from Results they have shown that mouse ficolins are versatile recognition 
molecules capable of binding to a wide range of opportunistic pathogens. Mouse ficolins 
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A and B might recognize different ligands on the bacterial surfaces extending and 
overlapping each other in their range of recognition. 
  
IV.4 Future studies 
 
Ficolin binding to different kinds of organisms was examined in previous studies by the 
groups of Matsushita, Krarup, and Lynch, but the exact structures involved in this 
interaction were not identified. The results of this work show no influence of 
encapsulation on the binding of mouse ficolins A and B to bacteria although no defined 
carbohydrate pattern could be found to be associated with positive binding.  
Due to the complex nature of these molecules the binding specificity of ficolins could be 
investigated by using the glycan-array technology to screen for different oligosaccharides 
including acetylated and non-acetylated carbohydrates, non-sugar molecules, etc.. 
Furthermore, competitive assays with single carbohydrates, non-sugar molecules would 
give an opportunity to define the exact molecules, which are recognized by mouse 
ficolins in different conformations and with different substitutions.  
Thus in future studies, homologues of non-capsulated and capsulated mutants may be 
included in control experiments. By having a Streptococcus pneumonia wild type strain, 
which could bind to ficolins and act as a positive control, it would be possible to use 
mutants of this particular strain which lacking one structure in the cell wall such as D-
alanine in teichoic and lipoteichoic acids in the mutant Δ dltA, lipoproteins in the strain Δ 
Lgt, lipoteichoic acid in the strain TagO and protein A in the mutant Δ Spa or the lack of 
O-acetylation in Δ OatA strain at peptidoglycan in the polysaccharide chain. By testing 
these mutants to ficolin binding it would be possible to localize the structure that causes 
adhesion between ficolins and bacteria. 
It remains to be tested to which extent the ficolin binding to acetylated carbohydrate 
molecules is relevant under physiological conditions in vivo. Considering that ficolin B is 
found in the lysosomes of activated macrophages (Runza et al., 2006) it would be 
interesting to elucidate the influence of low pH on the ficolin-bacterial interaction. 
Garlatti and colleagues investigated this interaction between acetylated compounds and 
M-ficolin at different pH and found that the ligand binding site of M-ficolin was 
dislocated.   
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During the past years, expression of recombinant M-ficolin allowed characterization of 
its recognition specificity for acetylated ligands and revealed a marked preference for N-
acetylneuraminic or sialic acid, a property not shared with L- and H-ficolins 
(Hummelshoj et al., 2008). Kjaer et al. show human serum M-ficolin binds to capsulated 
isolates of a pathogenic bacterium, namely Group B Streptococcus, and identify sialic 
acid as the bacterial ligand. Interestingly, this pathogen is recognized neither by L- and 
H-ficolins nor by MBL. Moreover, they demonstrate that binding of M-ficolin to the 
bacteria triggers complement activation, which strongly suggests that serum M-ficolin 
acts as a soluble PRR similar to L-ficolin and MBL. This clearly opens the way to the 
search for other pathogenic bacteria, fungi, or parasites that express sialic acids on their 
surfaces (Varki et al., 2008) as potential M-ficolin targets. The possible collaboration of 
serum M-ficolin with other soluble PRRs, such as PTXs (PTX3, C-reactive protein, 
serum amyloid protein), should also be investigated.  
Mouse ficolin B seems to recognize terminal N-acetylneuraminic acid residues present in 
molecules like SiaLacNAc and fetuin (Endo et al., 2005), suggesting that the cell 
associated ficolin B, in addition to bacterial recognition, might have other functions 
related to cellular host events (Runza et al., 2008 ) and recognition of other pathogenic 
bacteria, fungi, or paracytes. 
In previous studies it was reported that L-ficolin recognizes malignant cells since they 
often undergo changes in their glycosylation pattern compared to normal cells (Kim et 
al., 1997). In this regard, the glycosylated structures found on mouse tumor cells might 
be susceptible to recognition by ficolins A and B. In a recent studies it was shown that 
recombinant FcnB binds to late apoptotic cells and to apoptotic bodies as well as to 
necrotic cells but not to early apoptotic cells (Schmid,
 
Hunold et al., 2011) This binding 
was calcium-dependent and could be competitively inhibited by acetylated BSA, a 
classical binding substrate of FcnB. In addition, DNA inhibited binding of FcnB to 
apoptotic and necrotic cells, indicating that DNA exposed by dying cells could also be a 
ligand for FcnB. Thus, FcnB may play a role in the removal of damaged host cells and 
maintenance of tissue homeostasis. Thererefore, it remains to be investigated, whether 
ficolin A and B are also involved in the immune surveillance of altered self.  
Furthermore, Jensen and Honore reported that L-ficolin binds to late apoptotic cells as 
well as to apoptotic bodies and necrotic cells, but not to early apoptotic cells. They also 
demonstrated that L-ficolin binds DNA in a calcium dependent manner suggesting that 
DNA on permeable dying cells act as plausible ficolin ligands (Jensen, Honore et al., 
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2006). Binding L-ficolin to DNA of permeable late apoptotic and necrotic cells might 
lead to enhanced uptake by macrophages (Jensen, Honore et al., 2007). Whether in the 
mouse system, ficolin A and B are involved in the clearance of dead cells raises a highly 
interesting question and remains to be investigated.  
Also, it would be interesting to investigate, whether ficolin B can change its GlcNAc-
binding activity in different still physiological pH-changes. Based on work of Yang L. 
and Zhang J., a detailed understanding of the pH-dependent conformational changes in 
M-ficolin and pH-mediated discrimination mechanism of GlcNAc-binding activity are 
crucial to both immune-surveillance and clearance of apoptotic cells (Yang, Zhang et al., 
2011).  
Finally, up to date it is not known whether mouse ficolins can bind to a variety of viruses, 
fungal cells (except Candida albicans which were found not be able to bind neither ficolin 
A or B), or promastigotes and, therefore, still remains as an interesting field to be 
explored. 
In any case there are several promising hypotheses concerning the functions of ficolins A 
and B that are in need of further investigation which would lead to a better understanding 
of these innate multifunctional proteins of the immune system. 
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